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ABSTRACT
CHARACTERIZATION OF CORTICOTROPIN-RELEASING FACTOR CELLS
IN THE MEDIAL PREFRONTAL CORTEX OF RATS
FEBRUARY 2016
YI-LING LU, B.S. NATIONAL CHENG KUNG UNIVERSITY, TAINAN, TAIWAN
M.S. NATIONAL YANG-MING UNIVERSITY, TAIPEI, TAIWAN
Ph.D., UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by: Professor Heather N. Richardson

Corticotropin-releasing factor (CRF) is the major peptide involved in regulating the
body’s autonomic, hormonal, and behavioral responses to stress. Cells that produce and
release this peptide are widely distributed throughout the brain. This dissertation focuses
on a specific population of CRF cells residing in the medial prefrontal cortex (mPFC) that
could potentially influence a number of higher order functions through modulation of local
circuits. The prefrontal cortex is known to function sub-optimally in patients suffering
from various stress-related psychiatric conditions including alcohol use disorder (AUD),
and dysregulated CRF signaling may be an underlying mechanism. Surprisingly little is
known about this population of cells. A primary objective of this dissertation was to
characterize these cells and determine how they fit anatomically and functionally into the
local circuitry of the mPFC. I show that although mPFC CRF cells are inhibitory
interneurons, a relatively small number of CRF puncta co-expressed the rate-limiting
enzyme for GABA production indicating that CRF and GABA may be independently
released. Co-expression patterns differed in the dorsal versus ventral mPFC indicating
anatomical diversity in the modulation of pyramidal circuits by CRF. These subtle
vii

differences in CRF micro-circuitry may facilitate a highly complex biological response to
stress. I also examined possible links between AUD vulnerability and mPFC CRF using
two models associated with increased drinking: predator odor stress and adolescent
binge drinking. Predator odor stress increased CRF cell density, but adolescent binge
drinking decreased CRF labeling intensity in the ventral portion of the mPFC. Thus, while
high mPFC CRF may promote heavy drinking, alcohol-induced increase in peptide
production does not appear to be the mechanism by which adolescent alcohol increases
vulnerability to AUD. No sex differences were observed in several measurements of the
CRF system in the mPFC of adolescent rats. Altogether my results suggest that CRF
cells differentially modulate the dorsal and ventral mPFC and may play a complex role in
alcohol drinking. These findings provide groundwork for understanding this peptidergic
system and should help direct future investigation aimed at elucidating the details of
CRF-mediated cellular and molecular mechanisms underlying functions regulated by the
mPFC.
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PREFACE
Chronic exposure to alcohol produces changes in the prefrontal cortex that are
thought to contribute to the development and maintenance of alcoholism. A large body of
literature suggests that stress hormones play a critical role in this process. Chapter 1 (Lu
and Richardson, 2014) reviewed the bi-directional relationship between alcohol and
stress hormones, and discussed how alcohol acutely stimulates the release of
glucocorticoids and induces enduring modifications to neuroendocrine stress circuits
during the transition from non-dependent drinking to alcohol dependence. A pathway
was proposed by which alcohol and stress hormones cause changes in prefrontal
circuits that results in a dampened neuroendocrine state and an increased propensity to
relapse—a spiraling trajectory that may eventually lead to dependence. I hypothesized
that these neuroendocrine and behavioral changes were due in part to neuroadaptations
in corticotropin-releasing factor (CRF) signaling in the prefrontal cortex. The aim of my
dissertation research was to take the essential first steps in testing this hypothesis by (1)
determining how these cells were impacted by life experiences with stress and alcohol,
and by (2) gaining a basic understanding of how CRF-peptide producing cells could fit
into local circuitry in the prefrontal cortex to modulate neuronal activity and function. The
CRF cells in the subregions of the medial prefrontal cortex (mPFC) were examined in
two different models that are known to increase the risk of alcohol use disorder: predator
odor stress (Chapter 2) and adolescent binge drinking (Chapter 3). I hypothesized that
an upregulated CRF system in the mPFC was a common underlying mechanism of
increased alcohol drinking in these two animal models. I also tested for sex differences
in this frontal neuropeptide system. In Chapter 4, mRNA and protein levels of mPFC
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CRF system were examined under baseline conditions in adolescent male and female
rats. Main findings from this dissertation are discussed in Chapter 5.

x
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CHAPTER 1
ALCOHOL, STRESS HORMONES, AND THE PREFRONTAL CORTEX:
A PROPOSED PATHWAY TO THE DARK SIDE OF ADDICTION
Lu Y-L, Richardson HN (2014) Neuroscience 277:139–151.
Abstract
Chronic exposure to alcohol produces changes in the prefrontal cortex that are
thought to contribute to the development and maintenance of alcoholism. A large body of
literature suggests that stress hormones play a critical role in this process. Here I review
the bi-directional relationship between alcohol and stress hormones, and discuss how
alcohol acutely stimulates the release of glucocorticoids and induces enduring
modifications to neuroendocrine stress circuits during the transition from non-dependent
drinking to alcohol dependence. I propose a pathway by which alcohol and stress
hormones elicit changes in prefrontal circuitry that could contribute functionally to a
dampened neuroendocrine state and the increased propensity to relapse—a spiraling
trajectory that could eventually lead to dependence.
Overview
Alcoholism is a neurobehavioral disorder characterized by compulsive seeking of
alcohol, excessive and uncontrolled intake, and the emergence of a negative emotional
state (e.g., irritability, anxiety, depression) when alcohol is unavailable (American
Psychiatric Association, 1994). Preclinical studies in rodents suggest that the transition
from alcohol use to abuse to dependence is due to alterations in stress-related neural
pathways resulting from exposure to repeated cycles of alcohol intoxication and
withdrawal (Heilig and Koob, 2007; Breese et al., 2011). Alcohol dependence is
characterized by impaired functioning of the hypothalamic pituitary adrenal (HPA) axis
1

(Adinoff et al., 1990; Wand and Dobs, 1991; Lovallo et al., 2000; Rasmussen et al.,
2000; Zorrilla et al., 2001; Richardson et al., 2008a). HPA dysfunction is thought to
contribute to a number of symptoms, including dysphoria, alcohol craving, and enhanced
propensity to relapse early in abstinence (Lovallo, 2006; Li et al., 2011; Sinha et al.,
2011; Stephens and Wand, 2012).
Here I review alcohol use disorder and describe how preclinical and clinical studies
together have implicated dysfunction of the HPA axis and prefrontal cortex in these
disorders. I first provide an overview of some of the preclinical rodent models that have
been designed to study drinking behavior at different stages of alcohol use disorder.
With the focus on evidence from these drinking models, I discuss the bi-directional
relationship between alcohol and stress hormones. The HPA axis undergoes
adaptations from non-dependent drinking to alcohol dependence and I examine some of
the mechanisms that may contribute to changes in stress hormone levels. Toward the
end of the review, I pull together information from various studies that supports the
following hypothesis: continued heavy use of alcohol causes glucocorticoid-mediated
adaptations within the HPA axis and upstream in the prefrontal cortex that lead to
neuroendocrine dysfunction and a heightened propensity to relapse. I posit that the
complex interplay between alcohol, stress hormones, and the prefrontal cortex may be a
critical factor in the transition from social drinking to problematic drinking and alcoholism.
More research should be directed toward exploring the possibility of adaptations in the
HPA dysregulation driven by alterations in the prefrontal cortex regulation over time.
These studies could provide a new avenue of therapeutic intervention that may be
extremely effective, as prefrontal dysfunction and HPA dysregulation are both thought to
play a functional role in escalation of drinking and relapse (Stephens and Wand, 2012).

2

Alcohol use disorder and prefrontal cortex
The prefrontal cortex integrates information from other cortical and subcortical
regions to functionally contribute to working memory, emotion regulation, and behavioral
control (Wilson et al., 2010; Kesner and Churchwell, 2011). Structural, physiological, and
behavioral deficits related to the prefrontal cortex have been observed in patients with
alcohol use disorder. These functional changes include reduced glucose metabolic rates,
cortical atrophy, decreased cognitive flexibility, and memory performance (reviewed in
Fadda and Rossetti, 1998; Moselhy et al., 2001; Stephens and Duka, 2008). In addition,
prefrontal deficits are tightly associated with HPA dysregulation in alcoholic men (Errico
et al., 2002). Because the prefrontal cortex provides top-down control over the HPA axis,
it is possible that neuroadaptive changes in this region could underlie some of the
changes in stress hormones (Lovallo, 2006; Herman, 2012). Neuroadaptations are the
molecular or biochemical changes to neurotransmitter systems brought on by repeated
exposure to drugs such as alcohol (Schulteis et al., 1995; Koob, 1996; Koob et al., 1998).
These adaptations are opponent processes that serve to reverse the effects of the drug
during

exposure.

However,

once

drugs

are

cleared

from

the

body,

these

neurotransmitter systems can become hypo- or hyperactive, further promoting continued
drug use to alleviate these effects, e.g., Schulteis et al., 1995. Preclinical animal models
can be useful tools for dissecting complex interaction between alcohol, stress hormones,
and the prefrontal cortex. I briefly describe these models below.
Animal models of alcohol use, abuse, and dependence
Preclinical rodent models aim to emulate as much as possible the human
experience with alcohol by capturing different drinking behaviors in the early, mid, and
late stages of addiction (Brown et al., 1980). Figure 1 provides an overview of
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commonly used rodent models of alcohol use, abuse, and dependence. For more
detailed discussion of the preclinical nonhuman primate models see Grant and Bennett,
2003; Barr and Goldman, 2006. When people consume alcohol, most of them drink lowto-moderate amounts, which is less than three drinks per day for men and less than two
drinks per day for women (Eckardt et al., 1998; Boschloo et al., 2011). Similarly, rodents
can be used to model this type of non-dependent drinking (Use, left column, Figure 1).
The positive reinforcing properties of the drug, such as pleasure, disinhibition and social
acceptance, are thought to be the primary forces driving motivation to consume alcohol
under non-dependent conditions (Eckardt et al., 1998).
Rodent models of voluntary alcohol abuse are designed to capture more
hazardous patterns of drinking (Abuse, middle column, Figure 1). Abuse-like drinking
patterns include escalations in intake, enhanced relapse after short or long withdrawal
periods, stress/cue/alcohol-induced reinstatement, and episodic alcohol consumption
resulting in some degree of intoxication. “Binge drinking” is an example of alcohol abuse.
This is classified as the consumption of enough alcohol within a two-hour period to
produce alcohol concentrations in the blood that reach an intoxication level of 0.08 g/dL
or higher (~4 drinks in women, ~5 drinks in men, NIAAA, 2004). Non-dependent alcohol
use can escalate to a pattern of abuse that may be brought on by additional factors such
as social pressure, age, genetic predispositions, and gender (Chassin et al., 2004; Oei
and Morawska, 2004; Ceylan-Isik et al., 2010; Silveri, 2012). Many of these same factors
influence drinking patterns in rodents, and these preclinical models have aided in the
identification of some of the neural correlates of risky drinking (Anacker and Ryabinin,
2010; Sherrill et al., 2011; Gilpin et al., 2012; Karanikas et al., 2013; McBride et al.,
2014).

4

A variety of strategies can be used to elicit voluntary binge drinking in animals, but
a common theme in most models is intermittent access to alcohol (Mcgregor and Gallate,
2004; Rhodes et al., 2005; Simms et al., 2008; Crabbe et al., 2009; Gilpin et al., 2012;
Sharko et al., 2013). If this episodic pattern of drinking persists, animals may begin to
show signs of motivational and emotional—but not physical—dependence (Cox et al.,
2013). Stress regulatory systems begin to undergo neuroadaptive changes and although
alcohol may still have positive reinforcing properties, the negative reinforcing properties
of alcohol are starting to become powerful motivators driving excessive drinking (Baker
et al., 1986; Koob, 2003; Sinha et al., 2009; Koob et al., 2014; Wise and Koob, 2014).
Chronic cycling between alcohol intoxication and withdrawal can cause an
individual to become dependent on alcohol (Becker, 2008) (Dependence, right column,
Figure 1). This shift from non-dependence to dependence has been described as a
transition from the light side to the dark side of addiction (Schulteis and Koob, 1994;
Koob and Le Moal, 2005). Laboratory rodents without a predisposition for addiction are
shifted from non-dependent baseline drinking to escalated and compulsive-like drinking
by combining voluntary drinking and forced alcohol exposure that induces mild to
moderate physical dependence (Roberts et al., 2000; Becker and Lopez, 2004; O'Dell et
al., 2004; Richardson et al., 2008a; Vendruscolo et al., 2012). By incorporating voluntary
drinking into the experimental design, preclinical studies have been useful for identifying
biological changes specifically associated with drinking behavior at these various stages
of alcohol use disorder (Roberts et al., 1996; Knapp et al., 1998; Sidhpura et al., 2010;
Gilpin et al., 2012; DePoy et al., 2013).
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Alcohol stimulates the release of stress hormones
When an organism experiences a physical or psychological challenge, neurons in
the paraventricular nucleus of the hypothalamus (PVN) release the 41-amino acid
peptide corticotropin-releasing factor (also known as corticotropin-releasing hormone)
from axonal terminals in the median eminence (Vale et al., 1981). Corticotropin-releasing
factor (CRF) travels through the short portal system, binds to its Type 1 G-protein
coupled receptor (CRF1) (Chang et al., 1993; Chen et al., 1993; Perrin et al., 1993), and
stimulates the release of adrenocorticotropic hormone (ACTH) from the anterior pituitary
gland (Rivier and Vale, 1983). ACTH is released into the bloodstream and within minutes
this hormone reaches its target cells in the adrenal gland to stimulate the release of
glucocorticoids (cortisol in primates, corticosterone in rodents, Rivier and Vale, 1983).
The first line of evidence demonstrating that alcohol is an acute stressor that
activates the HPA axis comes from studies in which alcohol-naïve animals are given a
bolus dose of alcohol using “forced” delivery methods such as intragastric injection, ig
(Ogilvie et al., 1997a), intubation/gavage (Pruett et al., 1998), intracerebroventricular
injection (Selvage, 2012), intraperitoneal injection, ip (Rivier, 1993), and vapor inhalation
(Rivier et al., 1984). This approach has been effective for identifying neural circuits that
are activated by acute alcohol intoxication and exploring the molecular mechanisms by
which alcohol can stimulate a stress hormone response. I briefly summarize these
findings below (for a more detailed review, see Rivier, 2014).
Experimenter-administered alcohol dose dependently elicits elevations in PVN
cellular activity and the release of ACTH and corticosterone in male and female rats
(Ellis, 1966; Rivier, 1993; Rivier and Lee, 1996; Ogilvie et al., 1997a; Willey et al., 2012).
The tight link between alcohol dose and HPA activity is further supported by correlated
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blood alcohol and stress hormone levels after an acute alcohol challenge (Ellis, 1966;
Ogilvie et al., 1997a). These findings suggest that alcohol may directly activate HPA axis
through regulating the PVN cellular activity. Indeed, in vitro application of alcohol to
hypothalamic tissue or primary hypothalamic cells induces the release of CRF (Redei et
al., 1988; Li et al., 2005). In addition, CRF heteronuclear RNA quickly elevates within 20
min after in vivo alcohol administration in rats (Rivier and Lee, 1996; Ogilvie et al., 1998).
This transcriptional process is presumably initiated to replenish cellular stores of this
peptide that were rapidly released from the nerve terminals in response to alcohol
stimulation. CRF mRNA expression increases thereafter and remains elevated up to 6
hours following ethanol administration (Zoeller and Rudeen, 1992).
Alcohol is also known to activate cells outside the PVN. An intoxicating dose of
alcohol administered ip or ig modulates Fos expression in the prefrontal cortex, bed
nucleus of the stria terminalis, central nucleus of the amygdala, and locus coeruleus
(Chang et al., 1995; Knapp et al., 2001). These targeted regions could regulate HPA
reactivity through direct or indirect pathways and provide another layer of regulation in
response to alcohol stimulation (Ulrich-Lai and Herman, 2009; Herman, 2012).
The acute effect of alcohol on stress hormones has been observed with voluntary
drinking in humans and animals. Voluntary alcohol drinking activates the HPA axis in
male rats (Richardson et al., 2008a; although see Korányi et al., 1987) and in men and
women (Jenkins and Connolly, 1968; Schuckit et al., 1987; Lex et al., 1991; Ekman et al.,
1994; King et al., 2006). These key findings demonstrate that alcohol acts as a stressor,
even if this drug is experienced through a natural route of administration. The HPA axis
has been hypothesized to be a biological system that is both sensitive to alcohol and
may also play a functional role in the progression from non-dependent drinking to abuse
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and dependence (Koob and Kreek, 2007; Richardson et al., 2008a; Stephens and Wand,
2012; Vendruscolo et al., 2012; Koob et al., 2014). As mentioned earlier, binge
drinking—but not moderate drinking—brings blood alcohol concentrations to a level of
intoxication. Consequently, engaging in this type of hazardous drinking will activate a
robust stress response, which could be costly to an individual if the pattern of abuse
continues (Romero et al., 2009; Koob et al., 2014). Moreover, the effects alcohol abuse
has on physiological and mental health may be more profound in individuals already
sensitive to stress. Sex differences in HPA reactivity are thought to contribute to
differential alcohol-related vulnerabilities in men and women (Adinoff et al., 2010; Lovallo
et al., 2012; Stephens and Wand, 2012).
Chronic exposure to alcohol leads to neuroendocrine tolerance
Chronic heavy alcohol use eventually leads to dampened functioning of the
neuroendocrine stress system and this dysregulated hormonal state may contribute to
some of the symptoms of alcoholism (Lovallo, 2006; Li et al., 2011; Sinha et al., 2011;
Stephens and Wand, 2012). Animal studies have elucidated some of the functional
changes in the HPA axis that emerge after varying degrees of prolonged alcohol
exposure in drinking models of addiction. Early in abstinence after chronic alcohol
exposure, basal/resting levels of ACTH and corticosterone are significantly lower at the
start of the inactive (light) phase of the light/dark cycle in dependent rats compared to
non-dependent rats, but this difference in basal hormone levels was not measurable in
the active (dark) phase (Richardson et al., 2008a). Blunted basal levels of corticosterone
have also been observed in both phases of the light/dark cycle in adult male rats weeks
after removal from chronic alcohol liquid diet, as compared to alcohol naïve-controls
(Rasmussen et al., 2000; Zorrilla et al., 2001).
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The most reliable indicator of chronic alcohol-induced changes in HPA function is a
reduced response of this neuroendocrine system to an acute challenge of alcohol—also
known as “neuroendocrine tolerance.” Neuroendocrine tolerance emerges after
prolonged drinking and the magnitude of decrease in neuroendocrine sensitivity to
alcohol appears to be dose-dependently related to the overall amount of alcohol
consumed. When animals are given an alcohol challenge of 1 g/kg iv—the dose of
alcohol that dependent rats voluntarily binge drink in a single 30-min session (Heyser et
al., 1997; Gilpin et al., 2009; Li et al., 2011)—HPA responses differ greatly across
individuals depending on their previous experience with alcohol (Richardson et al.,
2008a). This 1 g/kg dose elicits binge-like blood alcohol levels in all animals (Figure 2A).
However, it stimulates robust ACTH and corticosterone responses in low-drinking nondependent rats, mid-range responses in moderate drinking non-dependent rats, and
blunted responses in high drinking dependent rats (Figure 2A).
Adaptations have been found at multiple levels within the HPA axis, which may
contribute to dampened neuroendocrine function after chronic alcohol. At the level of the
hypothalamus, CRF mRNA expression is reduced in dependent animals 6-8 hours after
withdrawal from chronic alcohol vapors compared to alcohol-naïve controls, and CRF
mRNA expression in non-dependent animals is intermediate to these two groups
(Figure 2B). Chronic alcohol consumption appears to reduce responsiveness of pituitary
corticotrophs to CRF peptide. A CRF challenge (0.3 µg/mL, iv, intravenous) elicits low
ACTH responses in non-dependent and dependent drinking rats relative to the
responses observed in alcohol-naïve rats (Figure 2C). However, alterations in pituitary
responsiveness does not appear to further progress with increased doses of alcohol, as
non-dependent and dependent rats have comparable ACTH responses after a CRF
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challenge (Figure 2C). Reduced pituitary responsiveness in drinking rats versus alcoholnaïve rats could be mediated by various mechanisms, including CRF1 receptor
expression within pituitary cells and changes within the arginine vasopressin system
(Ogilvie et al., 1997b; Zhou et al., 2000).
Although mechanisms downstream of the pituitary were not explored in
Richardson et al. (2008a), the fact that a 1 g/kg (iv) alcohol challenge in the dark phase
of the light/dark cycle elicited a similar timeline of change in ACTH in the three drinking
groups, but a much more prolonged corticosterone response in the low-drinking nondependent rats suggests that even moderate drinking may alter adrenal sensitivity to
ACTH (Figure 2A). Alcohol-induced alterations in splanchnic innervation of the adrenal
glands could explain such group differences (Ulrich-Lai et al., 2006). The mechanisms
upstream of the hypothalamus are largely unknown, but enhanced inhibitory tone from
peri-PVN GABA cells or other direct and indirect targets of the prefrontal cortex are
possible candidates (Li et al., 2011; Herman, 2012). Later in this review, I discuss in
detail a proposed role for the prefrontal cortex in neuroendocrine tolerance after chronic
alcohol use and dependence (see Figure 4).
Neuroendocrine tolerance may trigger relapse and heavy drinking
As described above, HPA dysregulation is a common symptom associated with
chronic alcohol abuse and dependence. Reduced stress hormone levels may not only be
reliable indicators of the addictive stage of an individual, but could also play a functional
role in driving escalated drinking and enhanced relapse. In support of this hypothesis,
blunted basal stress hormone levels in alcoholics predicts craving (Kiefer et al., 2002).
There is also a strong temporal relationship between dampened HPA hormone levels
and increases in heavy drinking and propensity to relapse early in abstinence in humans
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(Gianoulakis, 1998; Kiefer et al., 2002; Junghanns et al., 2003; Adinoff et al., 2005b;
2005c; 2005a; Sinha et al., 2011) and in rodents (Rasmussen et al., 2000; Richardson et
al., 2008a; Li et al., 2011). Additionally, the opiate receptor antagonist, naltrexone,
stimulates the HPA axis and blocks alcohol craving and self-administration in alcoholdependent human subjects (O'Malley et al., 2002).
Transgenic manipulations of CRF1 receptors in animals demonstrate that
elimination of CRF1 receptors specifically from the central nervous system while leaving
pituitary CRF1 receptor expression intact reduces relapse-like drinking (Molander et al.,
2012). However, if pituitary CRF1 receptors are also eliminated—as with the CRF1 null
knockout—HPA hormones are dampened and relapse-like drinking increases (Molander
et al., 2012). This is consistent with the hypothesis that during a drinking session
alcohol-induced

stimulation

of

ACTH

and

possibly

its

downstream

hormone

corticosterone curbs alcohol drinking. Other predictions of this hypothesis have been
tested using pharmacological approaches. Blocking inhibitory tone on the PVN using
GABAA receptor antagonists such as picrotoxin or bicuculline is known to increase HPA
activity (indexed by elevated Fos-immunoreactivity in the PVN and elevated blood
corticosterone levels) in alcohol-naïve rats (Cole and Sawchenko, 2002) and alcoholdependent rats (Li et al., 2011). This treatment also prevents relapse-like drinking in
animals exposed to an intermittent drinking paradigm (Li et al., 2011).
While the findings above suggest that dampened HPA activity may stimulate
relapse and heavy drinking, the interplay between low peripheral glucocorticoid levels
and drinking behavior is not so clear. Acute blockade of corticosterone synthesis through
metyrapone administration fails to elevate (Besheer et al., 2013)—and may even block
(Fahlke et al., 1994)—alcohol drinking behavior. This suggests that low glucocorticoid
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levels do not cause increases in drinking, at least under non-dependent conditions.
Perhaps deficits in HPA reactivity upstream of the adrenal glands are driving forces in
increased drinking (Li et al., 2011). In addition, dampened glucocorticoids may acutely
drive heavy drinking and relapse only after key behavioral circuits have undergone
significant neuroadaptive changes associated with dependence. To the best of our
knowledge, this hypothesis has not been empirically tested.
Role of glucocorticoids in the transition to dependence
Even with chronic alcohol dampening the neuroendocrine stress system,
glucocorticoids still play a powerful role in the transition to dependence. Chronic
exposure to alcohol drinking or to vapor-induced bouts of intoxication leads to dampened
peripheral glucocorticoid levels (Richardson et al., 2008a; Silva et al., 2009), yet
glucocorticoid signaling is required for the development of the physical, motivational, and
cognitive syndromes associated with alcohol dependence in rodents (Sze, 1977; Jacquot
et al., 2008; Vendruscolo et al., 2012). This seems paradoxical, but two important factors
must be considered. First, chronic alcohol exposure reduces—but does not fully
diminish—the ability of alcohol exposure to acutely elevate plasma levels of
corticosterone (Rivier et al., 1984; Lee and Rivier, 1997; Richardson et al., 2008a). In
fact, corticosterone levels remain significantly elevated for several hours during the
intoxication phase of chronic vapor treatment in neuroendocrine-tolerant animals (Rivier
et al., 1984; Lee and Rivier, 1997). Second, as individuals experience repeated bouts of
intoxication, the brain undergoes neuroadaptive changes that eventually promote the
emergence of a withdrawal syndrome (Koob, 2013). It is thought that the withdrawal
syndrome worsens over time, and at this point, periods of prolonged withdrawal could be
a second phase in which brain circuits are exposed to high concentrations of
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glucocorticoids that may be synthesized centrally (Brooks et al., 2008; Little et al., 2008).
Consequently, repeated cycling between binge intoxication and periods of withdrawal
would conceivably give this stress hormone ample opportunity to act on its receptors in
the brain and affect transcriptional regulation of multiple genes that could promote
addiction.
To understand how glucocorticoid signaling could promote—and glucocorticoid
type II receptor (GR) antagonists could block—the transition to dependence and
increase the probability of relapsing after abstinence (Vendruscolo et al., 2012), I must
consider the dynamic interplay between glucocorticoid levels and their receptors. As
illustrated in Figure 3, glucocorticoid signaling in the brain is thought to be a complex
process as individual’s transition from abuse to dependence. Blood levels of this stress
hormone fluctuate with the pattern of alcohol exposure (Figure 3B) and brain
responsiveness to corticosterone also changes because of receptor auto-regulation
(Sapolsky et al., 1984; Sapolsky and McEwen, 1985; Herman and Spencer, 1998).
Accordingly, differential GR expression in the brain might give insight into which brain
regions have high or low local concentrations of corticosterone during the intoxication
and withdrawal phases of chronic alcohol exposure. GR expression levels differ in early
versus late abstinence from chronic alcohol (Vendruscolo et al., 2012). GR mRNA
expression is reduced in frontolimbic brain regions 24h into withdrawal from chronic
intermittent vapors, but is normalized—or even elevated—in these same regions 3
weeks after cessation of chronic intermittent alcohol treatment (Vendruscolo et al., 2012).
Down-regulated GR mRNA expression in early abstinence could reflect the recent
hormonal environment in these frontolimbic regions during the 14-h intoxication phase of
intermittent vapor treatment (Rivier et al., 1984).
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After removal from chronic alcohol treatment, peripheral corticosterone levels can
remain dampened for several weeks into abstinence (Rasmussen et al., 2000; Zorrilla et
al., 2001)—perhaps resulting in a compensatory elevation in GR expression within some
of these brain regions important for addiction. In animals that have been exposed to high
levels of alcohol for several months, abstinence is characterized by increases in
prefrontal concentrations of glucocorticoids and heightened glucocorticoid/GR signaling
(Brooks et al., 2008; Little et al., 2008). This could explain why repeated periods of
abstinence and relapse are key elements of alcoholism (Koob and Le Moal, 2001).
Figure 3C shows a hypothetical model of how GR expression may change in the brain
in response to peripheral fluctuation of glucocorticoids throughout the induction of
dependence and into early and late abstinence. The complex interplay between
intermittent exposure to alcohol and changes of GR responsiveness in the brain may
lead to further neuronal adaptation and behavioral changes such as escalated and
compulsive drinking, and increased probability of relapse after abstinence.
Glucocorticoids may target the medial prefrontal cortex (mPFC) to produce some
of the neuroendocrine and behavioral changes associated with dependence
Glucocorticoids initiate non-genomic and genomic cellular events that provide both
immediate and long-term effects, respectively (Kolber et al., 2008). The fluctuating levels
of glucocorticoids during alcohol intoxication and after abstinence, as described above,
could induce assorted adaptation processes in the brain. Although there are most likely
several targets undergoing GR-mediated neuroadaptive changes following chronic
alcohol, here I focus on the prefrontal cortex—a region of the brain known for this role in
executive functions and regulation of emotions and behavior (Wilson et al., 2010; Kesner
and Churchwell, 2011).
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As shown in Figure 4, mPFC may play a role in the long-loop negative feedback of
the HPA axis (Sullivan and Gratton, 2002a). The GR has a four to five fold higher
prevalence than mineralocorticoid receptor (MR) in the mPFC, which is notably different
from the equal distribution of GR and MR in the hippocampus (Diorio et al., 1993; Cintra
et al., 1994). Implantation of corticosterone pellets in the dorsal portion of the mPFC
(dmPFC), to mimic high stress-like levels, attenuates HPA response to restraint stress
(Diorio et al., 1993; Akana et al., 2001). Although there are no direct projections from the
mPFC to the PVN, the mPFC may modulate the HPA axis through other brain regions
such as the bed nucleus of stria terminalis and the amygdala (Figure 5, Sakanaka et al.,
1986; McDonald, 1987; Hurley et al., 1991; Takagishi and Chiba, 1991; Moga and Saper,
1994; Dong et al., 2001a; 2001b; Crane et al., 2003a; 2003b; Spencer et al., 2005;
Radley et al., 2009; Beckerman et al., 2013). Activation of the dmPFC dampens HPA
responses, whereas lesions of the dmPFC produce exaggerated HPA responses (Diorio
et al., 1993; Figueiredo et al., 2003; Radley et al., 2006; 2008; Jones et al., 2011). I
hypothesize that corticosterone activates cells in the dmPFC that project to subcortical
structures and inhibit HPA axis activity. In vitro studies support this hypothesis showing
that corticosterone administration suppresses local GABA release in the dmPFC
(prelimbic cortex)—a disinhibitory effect that would, in turn, lead to higher pyramidal cell
activation and strengthen the overall dmPFC attenuating effect on HPA activity (Hill et al.,
2011).
In rodents, the mPFC is anatomically similar to the cingulate and premotor cortices
of the frontal lobes in primates (Reep et al., 1987). The rodent mPFC also has functional
similarity to the dorsolateral prefrontal cortex in primates (Kolb, 1984; Birrell and Brown,
2000; Barense et al., 2002; Seamans et al., 2008; Kesner and Churchwell, 2011).
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Chronic alcohol abuse and alcohol dependence can result in impaired performance on
cognitive tasks associated with integrity of the mPFC (George et al., 2012; Kroener et al.,
2012), suggesting that this region undergoes neuroadaptive changes with prolonged
exposure to moderate to high alcohol levels. I posit that repeatedly engaging in binge
alcohol exposure stimulates HPA axis activity and leads to enduring GR signaling within
the mPFC that produce changes in functions dependent on this region. In support of this
hypothesis, chronic alcohol results in low mPFC GR mRNA expression and heavy,
compulsive-like drinking behavior in male rats, but chronic treatment with a GR
antagonist prevents the development of this behavioral phenotype (Vendruscolo et al.,
2012). Acute treatment with a GR antagonist also reduces the mPFC-mediated memory
deficit observed during acute withdrawal from chronic alcohol treatment in mice (Jacquot
et al., 2008). Altogether, the findings suggest that prolonged exposure to alcohol impacts
cognitive performance and addiction-related behaviors through glucocorticoid signalinginduced changes in the mPFC.
CRF in the mPFC: a potential role in neuroendocrine tolerance
Aversive stimuli induce release of CRF in the mPFC (Merali et al., 2008), and
heavy alcohol drinking may have the same effect. George et al. (2012) reported that
after five months of intermittent alcohol drinking, the number of CRF cells in the mPFC
was elevated one day after withdrawal from alcohol. However, if rats were allowed to
drink for two hours, CRF cell counts were normalized. These results show that this
population of CRF cells undergoes neuroadaptive changes after chronic alcohol that can
be temporarily reversed by drinking heavily. Prefrontal CRF cells express GR, and GR
negatively regulates CRF mRNA levels (Meng et al., 2011). Because alcohol vapor
treatment induces a decrease in GR expression in the mPFC, it is possible that this
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would cause an increase in the CRF expression in this region after chronic alcohol
exposure. Increased CRF signaling could modulate local pyramidal cell activity in the
mPFC. CRF has been shown to decrease afterhyperpolarization current, which would
increase the likelihood of action potential firing (Hu et al., 2011). CRF also increases
spontaneous EPSC frequency in layer V pyramidal neurons (Liu et al., 2015). Thus, high
expression of CRF may promote local cellular activity in the PrL and contribute to blunted
HPA axis after alcohol dependence.
The prefrontal CRF system may also play a role in some of the behavioral
symptoms associated with alcohol dependence. Activation and blockade of CRFR1 in
the mPFC increases and decreases anxiety-like behaviors, respectively (Jaferi and
Bhatnagar, 2007; Bijlsma et al., 2011; Ohata and Shibasaki, 2011; Refojo et al., 2011).
Enhanced CRF signaling in the mPFC after chronic alcohol could increase anxiety-like
behaviors and promote negative reinforcing/self-medicating loops that lead to the dark
side of alcohol addiction.
Conclusions
I propose that acute stimulation of the HPA axis during repeated bouts of
intoxication and the subsequent adaptation within this neuroendocrine axis and
upstream in the prefrontal cortex are key factors in the transition from alcohol use to
abuse and eventually to dependence. As individuals engage in repeated cycles of
intoxication, abstinence, and relapse, a dynamic cascade of glucocorticoid signaling
could trigger a series of neuroadaptive events in the prefrontal cortex that have broad
implications on neural functioning and behavior. Other important factors modulating the
development of alcohol use disorder are beyond the scope of the current review.
However, these factors are worth noting and have been reported elsewhere: age onset
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of alcohol use/abuse (e.g. Dawson et al., 2008; Gilpin et al., 2012), substance couse/abuse with alcohol (e.g. Hanson et al., 2008), genetic/epigenetic regulation (e.g.
Tabakoff et al., 2009; Nieratschker et al., 2014), social components of drinking (e.g.
Butler et al., 2014), sex differences (e.g. Fox et al., 2009; Wemm et al., 2013), other
neurotransmitter/neuromodulator systems (e.g. Clapp et al., 2008; Gilpin, 2012) and the
potential lateralized stress regulation in the prefrontal cortex (e.g. Sullivan and Gratton,
2002b). It is worth noting that the animal housing condition may be a factor that interacts
with the alcohol drinking behavior and neural adaptations. The individual housing is often
incorporated in the experimental during the drinking period or throughout the entire
experiment. Single housing is known to induce stress (Greco et al., 1992) and increase
voluntary alcohol consumption in rats (Yoshimoto et al., 2003). On the other hand, group
housing may produce psychosocial stress from the hierarchy especially in male rodents
(Pohorecky, 2010). Therefore, the potential stress effect from various housing conditions
should be considered when interpreting alcohol effects in these studies.
Three important next steps in the field should be to (1) explore how glucocorticoid
signaling changes within the prefrontal cortex during use, abuse, and dependence, (2)
determine how alcohol and glucocorticoids interact to produce molecular and circuit-level
neuroadaptive changes in the prefrontal cortex to impact downstream targets and alter
neuroendocrine, autonomic, and behavioral functions related to stress and addiction,
and (3) develop a deeper understanding and appreciation for the importance of sex,
developmental status, and individual differences in this preclinical research, as most of
the animal literature cited in this review was based on studies using adult male rodents.
Gaining a new understanding the complex interplay among alcohol drinking, stress
hormones, and the prefrontal cortex would provide further information in the

18

development of new biomarkers to identify the progression of alcohol dependence and
help guide the discovery of new promising treatments for alcohol use disorder.
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Figures and Tables

Use

Abuse

Dependence

Behavioral Characteristics and Symptoms
When alcohol is available
Baseline drinking

Escalated intake (relative to baseline)
Enhanced relapse after deprivation from
alcohol (tested every few days/weeks;
increase relative to baseline or daily
testing)

Drinking behaviors similar to those
described for abuse (binge, relapse)
Compulsive alcohol drinking (seek alcohol
despite adversive consequences)
Work harder for alcohol (increased
progressive ratio break points)

When alcohol is not available
No evidence of a physical
or emotional/motivational
dependence

No evidence of a physical dependence;
possible emergence of
emotional/motivational dependence

Withdrawal syndromes
- Physical signs
Hyperactivity (mild); seizures (severe)
- Emotional/motivational signs
Anxiety-like and depression-like
behavior; Reward deficits (ICSS);
heightened sensitivity to pain

Target Blood Alcohol Levels (BALs) during Drinking
< 0.08 g/dL

≥ 0.08 g/dL

≥ 0.08 g/dL

Examples of Preclinical Drinking Models
Operant self-administration
of unsweetened alcohol
(e.g., Green and Grahame
2008, Weiss et al., 1993)
Home cage drinking of
unswetened alcohol
(e.g., June et al., 1994;
Avena et al., 2004)

Drinking in the dark (DID)
(e.g., Rhodes et al., 2005, 2007;
Cox et al., 2013)

Chronic exposure to alcohol diet, induction
BAL is usually 0.15 - 0.25 g/dL (e.g.,
Rassnick et al., 1992; Knapp et al., 1998)

Operant binge self-administration of
sweetened alcohol (e.g., Gilpin et al.,
2012; Karanikas et al., 2013)

Operant or home cage drinking followed
by different dependence induction methods

Home cage drinking of sweetened
alcohol or beer (e.g., Ji et al., 2008;
McGregor and Gallate, 2004)

- alcohol vapor exposure, induction BAL
is usually 0.15 - 0.25 g/dL (e.g.,
Roberts et al., 1996, 2000; O’Dell et al.,
2004; Becker and Lopez, 2004)

Chronic home cage drinking, intermittent
access to 20% w/v ethanol (e.g., Simms
et al., 2008)

- gavage alcohol delivery, induction BAL
is usually 0.20 - 0.45 g/dL (e.g.,
Sidhpura et al., 2010)

Figure 1. An overview of preclinical rodent models capturing different drinking
behaviors in the early (Use), mid (Abuse), and late (Dependence) stages of
alcohol addiction.
Behavioral characteristics and symptoms are described for each phase under conditions
when alcohol is available versus conditions when alcohol is unavailable (withdrawal).
The blood alcohol levels reached during a drinking episode differs as well, with use
always remaining below the ‘‘binge’’ limit (0.08 g/dL) during the Use phase, but
exceeding this level during the phases of Abuse and Dependence. I have provided a few
examples of models used to capture drinking behavior at each phase, but it should be
noted that this is not an exhaustive list. Abbreviation: ICSS, intracranial self-stimulation.
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Figure 2. The hypothalamic pituitary adrenal (HPA) axis is functionally different
depending on an individual’s prior experience with alcohol.
Data were obtained from adult male rats that were either naïve (no operant training or
previous exposure to alcohol), low-drinking non-dependent (several weeks of low levels
of alcohol-self administration), non-dependent (several weeks of moderate levels of
alcohol-self administration), or dependent (several weeks of moderate levels of alcohol
self-administration followed by chronic alcohol vapor-induced dependence). All
measures were taken when dependent animals were in acute withdrawal (6–8 h after
removal from chronic alcohol vapors). (A) The level of dampened HPA activity in
response to 1 g/kg iv alcohol challenge depends on animals’ alcohol responsiveness
and the alcohol exposure history. (B) CRF mRNA expression is low in the hypothalamus
of dependent compared to alcohol-naïve controls, and CRF mRNA expression in nondependent animals is intermediate to these two groups. (C) A CRF challenge (0.3 lg/kg,
iv) elicits a lower ACTH response in drinking rats relative to alcohol-naïve controls, but
the non- dependent and dependent groups do not differ from one another. Abbreviations:
iv, intravenous; pPVN, parvocellular division of paraventricular nucleus of the
hypothalamus; mPVN, magnocellular division of PVN; 3 V, third ventricle. [Adapted from
Richardson et al., 2008 European Journal of Neuroscience.]
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CHRONIC INTERMITTENT VAPORS
(DEPENDENCE INDUCTION)
Intox
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Normal CORT rhythm
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Figure 3. A schematic illustrating proposed alterations in alcohol levels in the
blood, corticosterone (CORT) in the blood and brain, and glucocorticoid receptors
(GR) in the brain before, during and after dependence induction.
(A) Blood and brain alcohol levels are strongly fluctuated during the intermittent alcohol
vapor exposure. In this example, vapors are delivered for 14 h, beginning at the onset of
the dark phase of the light/dark cycle. (B) Alcohol vapor stimulates CORT release to
levels far exceeding the normal diurnal rhythm of plasma CORT. Neuroendocrine
tolerance develops throughout the induction period and eventually leads to the
dampened HPA activity. (C) GR level in the brain decreased in response to the high
CORT during the high alcohol period. On the other hand, increased brain CORT after
dependence is hypothesized to come from de novo local synthesis or alterations in
blood–brain barrier permeability or both after alcohol dependence. Abbreviations: Intox,
intoxication; WD, withdrawal.
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Figure 4. A proposed model illustrating differential prefrontal regulation of the
HPA axis after alcohol use (A) versus alcohol dependence (B).
Dorsomedial prefrontal cortex (dmPFC) in rats modulates HPA activity by activating the
inhibitory control over PVN via the BNST or periPVN (Radley et al., 2006, 2009). Chronic
alcohol exposure has been proposed to increase the local de novo glucocorticoid
synthesis in the PFC (Little et al., 2008). Additionally, ex vitro studies demonstrate that
glucocorticoids reduce GABA inhibition of layer V pyramidal cells in the dmPFC (Hill et
al., 2011). Thus, the chronic alcohol-induced overflow of glucocorticoids in the dmPFC
could strengthen its output to downstream targets such as the BNST and periPVN,
resulting in stronger inhibition of the PVN and neuroendocrine tolerance. Abbreviations:
dmPFC, dorsal medial prefrontal cortex; vmPFC, ventral medial prefrontal cortex; BNST,
bed nucleus of the stria terminalis; periPVN, peri-paraventricular nucleus of the
hypothalamus; PVN, paraventricular nucleus of the hypothalamus; ACTH, adrenocorticotropic hormone; CRF, corticotropin releasing factor.
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Figure 5. Indirect modulation of the hypothalamic-pituitary-adrenal axis by the
medial prefrontal cortex.
A. The medial prefrontal cortex (mPFC) projects to subcortical structures such as the
bed nucleus of the stria terminalis (BNST) and central amygdala (CeA) to provide
indirect modulation of the hypothalamic-pituitary-adrenal (HPA) axis. Activation of the
dmPFC increases the inhibitory control of the PVN CRF cells via vBNST and periPVN.
Activation of the vmPFC increases the excitatory control of the PVN CRF cells via
indirect modulation in the dlBNST, vBNST, and CeA. Green cells, CRF cells; gray cells,
excitatory inputs; red cells, inhibitory inputs. Numbers adjacent to the lines indicate
corresponding references. B. Proposed roles of prefrontal CRF in the development of
alcohol use disorder. Predator odor stress and adolescent binge drinking are two models
that increase risk to alcohol use disorder. An upregulated extrahypothalamic CRF
system and a dampened hypothalamic CRF system are associated with escalated
alcohol drinking. It is proposed that an increase of prefrontal CRF would be shown in the
early phase of the development of alcohol use disorder before an increase in the CRF
populations in the amygdala and BNST and phenotypes such as dampened HPA axis
and increased anxiety. Abbreviations: ACTH, adrenocorticotropic hormone; CeA and
BLA: central nucleus and basolateral nucleus of the amygdala; dmPFC and vmPFC:
dorsal and ventral medial prefrontal cortex; dmBNST, dlBNST, vBNST: dorsomedial,
dorsolateral, and ventral bed nucleus of the stria terminalis; PVN, paraventricular
nucleus of the hypothalamus.
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CHAPTER 2
INDIVIDUAL DIFFERENCES IN STRESS-INDUCED ADAPTATIONS OF
CORTICOTROPIN-RELEASING FACTOR CELLS IN THE MEDIAL PREFRONTAL
CORTEX ASSOCIATE WITH AVOIDANCE LEVELS IN ADULT MALE RATS
Abstract
Stress-related disorders are often comorbid with alcohol use disorder (AUD).
Corticotropin-releasing factor (CRF) has been implicated in each of these disorders but
the location of CRF dysregulation is not known. I hypothesized that a population of CRF
cells residing in the prefrontal cortex underlies the comorbidity between stress disorders
and AUD, as this region is critical for executive functions such as decision-making and
regulation of emotions. To test this hypothesis, I used a predator-odor conditioned place
aversion model in adult male rats. Based on their avoidance of the odor-paired context,
stressed rats were divided into Avoiders (stress-vulnerable) and Non-Avoiders (stressresilient). Controls were never exposed to predator odor. Rats were euthanized at
baseline and CRF was examined using immunolabeling methods in the dorsal and
ventral portions of the medial prefrontal cortex (dmPFC and vmPFC, respectively),
central nucleus of the amygdala (CeA), dorsolateral portion of the bed nucleus of the
stria terminalis (dlBNST), and paraventricular nucleus of the hypothalamus (PVN). I
found that under baseline conditions, Avoiders had higher CRF cell density in the
vmPFC compared to Non-Avoiders and Controls, and this correlated with more
avoidance behavior. CRF was not altered by stress in the in the CeA, dlBNST, and PVN.
To further examine whether the increased CRF population in the vmPFC were involved
in the stress reactivity, another group of animals went through the same stress exposure
and were euthanized shortly after re-exposure to the odor-paired context. Using
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phosphorylated extracellular-signal related kinase (pERK) as an activity marker, I found
that re-exposure to the predator odor context activated a smaller percent of CRF cells in
the dmPFC in Avoiders that exhibited the highest avoidance behavior. These results
indicate that predator odor stress induces differential adaptive processes in CRF
populations within the dmPFC and the vmPFC. Imbalance of these neuromodulatory
populations of CRF cells in the mPFC may functionally contribute to differential stress
reactivity and coping strategy among individuals.
Introduction
Stress-related disorders, such as anxiety, depression, and posttraumatic stress
disorder (PTSD), are often comorbid with alcohol use disorder (AUD). Individual
differences in stress reactivity and coping strategy determine how likely a person
experiences and recovers from these conditions. Corticotropin-releasing factor (CRF)
and its receptors have been implicated in these disorders. Patients with PTSD and AUD
show elevated CRF levels in the cerebrospinal fluid (see review Arborelius et al., 1999).
In preclinical models for PTSD and AUD, sensitized CRF system in the brain contributes
to increased anxiety, pain sensitivity, and alcohol consumption. Blockade of type 1 CRF
receptor (CRFR1) during the disease state reduces these symptoms (Egli et al., 2012;
Koob et al., 2014). It has been proposed that individual differences in CRF contribute to
stress reactivity and coping strategy. Abnormal regulation of CRF may lead to the
development and maintenance of these pathological conditions.
To investigate if CRF is involved in the link between AUD and PTSD, a model of
traumatic stress was used. In this model, predator odor exposure is used to screen for
individual differences in stress sensitivity. Based on avoidance to odor-paired context,
stressed rats are divided into Avoiders (stress-vulnerable) and Non-avoiders (stress26

resilient). Avoiders, but not Non-avoiders, display persistent avoidance behavior, a
blunted neuroendocrine stress response, and escalated and compulsive drinking
(Edwards et al., 2013; Whitaker and Gilpin, 2015). These behavioral and neuroendocrine
phenotypes reflect the comorbidity between stress sensitivity and AUD in this model. In
particular, the escalated drinking phenotype positively correlates with avoidance level
and can be reversed by systemic administration of a CRF receptor antagonist (Roltsch et
al., 2014). These results suggest that CRF is upregulated in avoiders after odor stress,
but the anatomical location of these cells remains unknown.
CRF is widely expressed throughout the brain in regions such as the medial
prefrontal cortex (mPFC). The rodent mPFC integrates information from other brain
regions and mediates complex behaviors. CRF is released from cells in response to an
acute stressor (Merali et al., 1998) and the mPFC CRF system has been shown to
modulate neuroendocrine stress responses and anxiety-like behaviors (McKlveen et al.,
2015). CRF peptide levels are differentially regulated between acute and chronic
stresses (Chappell et al., 1986). These findings suggest that the prefrontal CRF system
is involved in stress modulation, and differential adaptations of this system between
stress-vulnerable and stress-resilient individuals may contribute to stress responses and
coping mechanisms.
The rodent mPFC can be functionally divided into dorsal and ventral subregions
(dmPFC and vmPFC, respectively). These two subregions anatomically receive and
send signals to different brain areas, which may contribute to functional differences such
as decreasing versus increasing neuroendocrine stress response, fear learning versus
extinction learning, or behavioral flexibility versus perseverance (Vertes, 2004; Hoover
and Vertes, 2007). Using the predator-odor exposure model, Edwards et al. (2013)
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reported differential reactivity to the odor-paired context between dmPFC and vmPFC. In
the vmPFC, Avoiders have higher cell activation than Non-Avoiders using pERK as an
activity marker, and this difference is not seen in the dmPFC (Edwards et al., 2013). As
both Non-Avoiders and Avoiders show similar cell activation in the amygdala
subdivisions after re-exposure to odor-paired context (Edwards et al., 2013), it is
possible that with the same emotional arousal, the reactivity of the mPFC differentiates
stress-induced behaviors between Non-avoiders and Avoiders.
Currently it remains unclear how the CRF system in the mPFC adapts after a
traumatic stress event, and whether the adaptation of this system contributes to the
differential stress reactivity between Non-Avoiders and Avoiders. Here, I test the
hypothesis that predator-odor stress leads to an upregulation in the CRF system of the
mPFC in stress-vulnerable Avoiders. Alternatively, avoidance behavior may be mediated
entirely by CRF cells outside the mPFC; for example, the CeA, dlBNST, and PVN, CRF
populations that are known to mediate negative affect states and stress responses. The
present study addressed these questions about prefrontal CRF using brains of control,
stress-vulnerable, and stress-resilient rats under baseline conditions (Experiment 1) and
after re-exposure to the predator-odor paired context (Experiment 2). It was predicted
that the avoider group, which had higher stress reactivity, would have more CRF cells in
the mPFC than Non-Avoiders. Moreover, when re-exposed to the odor-paired context,
Avoiders have higher pERK levels in the vmPFC than Non-Avoiders (Edwards et al.,
2013). It is possible that this heightened activity to odor-paired context in Avoiders was
contributed by an increase in CRF cell activation in the vmPFC. Support of the
hypothesis would suggest that stress-induced adaptation in the mPFC CRF system
modulates the circuitry balance within the mPFC, which can predispose stress-
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vulnerable individuals to persistent avoidance and escalate drinking. Contradiction of the
hypothesis would suggest that the mPFC CRF system plays a minor or indirect role in
the behavioral phenotypes of stress-vulnerable individuals after predator-odor stress.
Materials and Methods
Animals
All behavioral procedures were conducted in our collaborator’s laboratory in the
Louisiana State University Health Sciences Center. Sixty-one male Wistar rats (Charles
River) weighing ~300 g at start of experiments were pair-housed in groups of two in a
humidity- and temperature-controlled (22°C) vivarium on a 12-hour light/dark cycle. Rats
were acclimated for one week before start of experiments. Behavioral tests occurred
during the dark period. Animals had ad libitum access to food and water throughout
experiments. All procedures were approved by the Institutional Animal Care and Use
Committee of the Louisiana State University Health Sciences Center and were in
accordance with the National Institute of Health guidelines. The numbers of rats in each
group of two experiments were nine Controls, twelve Non-Avoiders, and ten Avoiders in
Experiment 1, and nine Controls, eleven Non-Avoiders, and ten Avoiders in Experiment
2.
Conditioned Place Aversion (CPA)
Adult male rats were exposed to predator odor (bobcat urine) or no odor in two
contexts that differ on visual and tactile cues with a connection triangle compartment. On
day 1, rats were allowed 5 min to freely explore the apparatus. On day 2, rats were
placed in one context with no odor for 15 min. On day 3, rats were placed in the other
context for 15 min, and a sponge soaked in bobcat urine (or no odor for controls) were
placed beside the cage. On day 4, rats were allowed 5 min to freely explore the
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apparatus once more (Figure 6A). Avoidance of predator odor-paired context was
quantified as post-conditioning time minus pre-conditioning time in the predator odorpaired context. Rats that exhibit more than a 10-second decrease in time spent in
predator odor-paired context were termed Avoider rats. All other stressed rats were
termed Non-Avoider rats (Edwards et al., 2013).
Perfusion and brain tissue sections processing
Eight days after the CPA procedure ended, animals in Experiment 1 were deeply
anesthetized and intracardially perfused with 4% paraformaldehyde in 0.1M borate buffer,
pH 9.5. In Experiment 2, animals were perfused 15 minutes after a 15-minute reexposure to the odor-paired context. This time point was chosen because a previous
report showed that Avoiders have higher pERK level in the vmPFC than Non-Avoiders
after the same treatment (Edwards et al., 2013). Brains were post-fixed in the same
fixative as above for 4 hours at 4ºC and submerged in 20% sucrose in 0.1M phosphate
buffer, pH 7.4 for 48 to 72 hours before being snap-frozen in isopentane (2-methylbutane,
Fisher Scientific) as previously described (Richardson et al., 2006). Rat brains were
shipped on dry ice to our laboratory at University of Massachusetts Amherst and frozen
brains were stored at -80ºC until they were sliced into 35 µm coronal sections on a
freezing microtome. Sliced sections were stored in cryoprotectant (30% ethylene glycol,
30% sucrose, and 1% polyvinylpyrrolidone in 0.1M phosphate-buffered saline) at -20ºC
before further processing.
Brain sampling
The Rat Brain in Stereotaxic Coordinates Atlas was used as an anatomical
reference (Paxinos and Watson, 2007). The sampling area for mPFC was 3.72 mm to
2.52 mm from Bregma. Subdivisions including the anterior cingulate cortex, prelimbic
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cortex, and infralimbic cortex were defined using the corpus callosum (forceps minor) as
an anatomical marker. Dorsal medial prefrontal cortex (dmPFC) included anterior
cingulate cortex and dorsal prelimbic cortex, and ventral medial prefrontal cortex
(vmPFC) included ventral prelimbic cortex and infralimbic cortex. I divided the mPFC into
the dorsal and ventral subdivisions (rather than the AC, PrL, and IL) to be consistent with
our collaborator’s previous report (Edwards et al., 2013). The sampling area for the CeA
was -2.16 mm to -3.24 mm from Bregma with serial sections spaced 175 µm apart, and
for the BNST was 0.00 mm to -0.36 mm from Bregma with serial sections spaced 175
µm apart.
CRF immunohistochemical labeling
For Experiment 1, the brain sections of interest were sorted out from
cryoprotectant. The extra cryoprotectant was rinsed away by 0.1M phosphate buffer
saline (PBS, pH7.4). Additional rinses with Triton X-100 containing PBS (PBST; 0.1M
PBS and 0.3% Triton X-100, pH7.4) were used to make the cell membrane finely porous.
A 30-minute 3% hydrogen peroxide (H2O2 in PBS) incubation was used to eliminate
endogenous peroxidase activity and this was followed by a blocking step of a 1-hour
incubation at room temperature with 5% non-fat milk in PBS. Rabbit anti h/r CRF
antiserum (C-72, 1:5,000, generously provided by Dr. Wylie Vale at the Salk Institute, La
Jolla, CA) was prepared in 5% non-fat milk and 10% normal goat serum in PBST. The
CRF antiserum incubation was 16 to 18 hours at 4ºC. After further PBST rinses, brain
sections were incubated with biotinylated goat anti rabbit IgG antiserum (1:200, Vector
Laboratories) in PBS for 2 hours at room temperature. Streptavidin conjugated
horseradish peroxidase (HRP) was applied for 1 hour at room temperature. The
chemical substrate for peroxidase, 3,3’-diaminobenzidine (DAB, Vector Laboratories)
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with nickel was used for the final color reaction. After immunolabeling, the sections were
mounted on gelatin-coated glass slides, dehydrated, and cleared before coverslipping.
The dehydration and clearing process includes 2 minutes in 70% ethanol, 2 minutes in
95% ethanol, two 2-minute rinses in 100% ethanol and three 5-minute rinses in xylene.
Slides were then coverslipped with DPX mounting media (Sigma-Aldrich) for microscopic
analysis.
Quantification of CRF cells in the mPFC
Slides containing prefrontal sections were digitally scanned at high resolution
(20X) under bright field illumination by Aperio ePathology (Leica Biosystems). Two
sections (350 µm apart from each other) containing CRF immunoreactive (CRF-ir) cells
were used as a representative of the CRF population. Given this distance in my
sampling interval and the fact that CRF cells are less than 10 µm in diameter and rarely
overlap with one another in the mPFC, it is unlikely that CRF cells would be double
counted in these studies. Nevertheless, to avoid biased sampling, I counted all CRF cells
in each subregion of the mPFC rather than using several small sampled regions of
interest. Dorsal and ventral mPFC were defined as described in the brain sampling
section above. The area of interest was traced and measured using ImageScope
software (Leica Biosystems). Experimenters blind to the treatment group counted CRF-ir
cells under 10X magnification of the slide images. The criteria for identifying CRF-ir cells
were a clearly defined border of the soma and evidence of extended neurites.
Quantification of CRF cells in the BNST and CeA
BNST sections were identified using anterior commissure as the anatomical
marker. Three sections (175 µm apart from each other, Karanikas et al., 2013) were
used for analysis of the CRF population in the BNST. Five CeA sections (175 µm apart
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from each other, Karanikas et al., 2013) were used for analysis of the CRF population in
the CeA. An experimenter blind to the treatment of the animal counted cells expressing
CRF peptide using a Nikon microscope at 400x magnification (40x objective and 10x
eyepiece) and a standard thumb-operated tally counter. Cells containing labeling
throughout the soma and neuronal processes, with a clear border around the soma were
considered CRF-ir and counted as described above. Adjusting the optical axis (z-axis) of
the microscope allowed for clearer visualization of the depth of the soma to better
distinguish the soma from a CRF-ir cell versus any ambiguous particle on the section.
Also, adjusting the z-axis allowed for clearer visualization of individual cell borders when
cells were clustered together (Gilpin et al., 2012).
Double immunofluorescent labeling
For Experiment 2, brain sections were sorted out and processed with hydrogen
peroxide and non-fat milk blocking steps as described above. An additional blocking step
with 50 mM ammonium chloride in PBST for 20 minutes was used to eliminate
endogenous fluorescence from the fixative. Sections were incubated with primary
antibody solution (rabbit anti-h/r CRF, C-68, generously provided by Dr. Paul Sawchenko
at the Salk Institute, La Jolla, CA, 1:20,000 in 3% goat serum) for 16 to 18 hours at 4ºC.
The next day, brain sections were incubated in biotinylated goat anti-rabbit IgG
antiserum (1:200, Vector Laboratories) in PBS for 2 hours at room temperature. The
signal was amplified by the streptavidin conjugated HRP after 1 hour incubation at room
temperature (ABC kit, Vector). AmplifluTM Red (1:5,000 in 3% H2O2/PBS, Sigma-Aldrich,
a red fluorescence substrate for HRP) was used for the enzyme reaction. After further
rinses, rabbit anti-pERK antibody (catalog #9101, Cell Signaling, 1:250 in 3% goat
serum) was applied for an incubation of 16 to 18 hours at 4ºC. On the third day, Cy2-
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conjugated goat anti-rabbit antiserum (1:700, Jackson Immunolaboratories) was used to
visualize the pERK labeling. A control group with CRF labeling followed by Cy-2
conjugated goat anti-rabbit antiserum incubation showed low or no interaction between
this secondary antiserum and CRF antiserum (data not shown). A counterstain of 4',6diamidino-2-phenylindole (DAPI, 1:10,000, Invitrogen) was used to visualize cell nuclei.
The labeled sections were mounted on gelatin-coated glass slides under a red light. The
glass slides were dried and coverslipped with DPX mounting media (Sigma-Aldrich) after
three brief xylene rinses (20 seconds, 1 minute, and 1 minute).
Confocal imaging
All images were acquired using a confocal microscope (A1R system, Nikon,
UMass Single Molecule/Live Cell Imaging Facility) with the Galvano detector and a 20X
objective. The same imaging conditions including laser intensity, gain, and offset were
used for all images. The sequential scanning method was applied with 4X averaging by
line for 1024 × 1024 frame size, and the pixel dwell time was 1.1 milliseconds. The
pinhole size was 1AU, and the step size for z-axis was 1 µm. Three to seven z slices
were taken for each sampling point. The final resolution was 0.41 µm per pixel.
Image analysis
All confocal images were analyzed using ImageJ software (Rasband, 1997). Each
z-stack image acquired from a single channel was combined using maximum projection
method. CRF, pERK, and double labeled cells were counted manually. Double labeled
cells were defined as a cell with soma filled with both CRF and pERK. For mean
fluorescent intensity, background labeling intensity was measured using three 1000-µm2
areas for each image. The values of background labeling intensity were averaged and
subtracted before the intensity measurement.
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Statistical analysis
The Grubbs test was used to identify outliers based on the avoidance level
(Komsta, 2011). Two rats, one Control and one Non-Avoider, were excluded from
analysis (Control, G = 2.36, U = 0.22, p < 0.01; Non-Avoider, G = 2.73, U = 0.26, p <
0.01). A one-way analysis of variance (ANOVA) was used to examine differences among
Control, Non-Avoiders, and Avoiders. Additional between-group comparisons were
conducted using a pairwise t-test with Bonferroni p-value adjustment. Differences
between the dmPFC and vmPFC were examined using a paired t-test. Pearson’s
correlation was used to analyze the relationship between avoidance and CRF
measurements. Differences were considered significant at p ≤ 0.05. All statistical
analyses were conducted using the R statistical software package (R Core Team, 2014).
Results
Figure 6A illustrates the experimental time line. Figure 6B shows avoidance levels
examined on the fourth day of the CPA procedure in two experiments. Controls had
significant differences in avoidance level when compared to Avoiders in the experiment 1
(t(12.29) = 2.75, p < 0.05) and when compared to Non-Avoiders in the experiment 2
(t(14.39) = -4.04, p < 0.01).
Experiment 1: Avoiders had more CRF cells in the vmPFC but not in the CeA,
dlBNST, and PVN
Figure 7A shows the sampled prefrontal sections, mPFC subregions, and a
photomicrograph of labeled CRF cells in the mPFC. The group differences among
Control, Non-avoiders, and Avoiders were analyzed using an ANOVA. CRF cell density
was significantly different among three groups in the vmPFC (Figure 7B, F(2,28) = 6.30,
p < 0.01). Post hoc analyses using a pairwise t-test with Holm p-value adjustment
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revealed that Avoiders have significantly greater density of CRF cells in the vmPFC
compared to Non-avoiders (p < 0.01) and Controls (p < 0.05). A group difference was
not detected in the dmPFC (Figure 7B, F(2,28) = 1.55, p > 0.05). In stressed animals
including Non-avoiders and Avoiders, a strong positive correlation was observed
between CRF cell number in the vmPFC and avoidance that was tested 24 hours after
the odor exposure (Figure 7B, R2 = 0.37, p < 0.01). A similar trend was also observed in
the dmPFC (Figure 7B, R2 = 0.18, p = 0.06).
There were no statistical differences in the BNST, PVN, and CeA (Figure 8). There
was a trend of negative correlation between avoidance behavior and CRF cell numbers
in the BNST (Table 1, R2=0.17, p=0.07). No correlation was found in the PVN (Table 1).
Experiment 2: The relationship between avoidance behavior and CRF activation
after re-exposure to the odor-paired context differed in Avoiders and NonAvoiders
Because Avoiders had more CRF cells in the vmPFC than Non-Avoiders and
Controls in Experiment 1, I reasoned that Avoiders would have more activated CRF cells
in the vmPFC than the other two groups after the context re-exposure. To test whether
Avoiders had more mPFC CRF cells activated in response to the stress-associated
stimuli compared to Non-Avoiders, animals were euthanized 15 minutes after a reexposure to the odor-paired context. Double immunolabeling of CRF and pERK were
used to examine the proportion of CRF cells that were activated after re-exposure to
odor-paired context. Figure 9A showed confocal fluorescence photomicrographs of
pERK (green) and CRF (red) in the dmPFC and vmPFC. A one-way ANOVA showed no
group differences in the percent of CRF cells that were activated in the dmPFC or in the
vmPFC (Figure 9B, dmPFC, F(2,25) = 1.1, p = 0.35; vmPFC, F(2,25) = 2.13, p = 0.14).
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Interestingly, this lack of a group effect may be explained by opposing relationships
between CRF activation and avoidance behavior in Avoiders versus Non-Avoiders. In
Avoiders, avoidance behavior negatively correlated with the percent of CRF cells that
were activated in the dmPFC—that is, a smaller percent of activated CRF cells was
associated with more avoidance (R2 = 0.64, p < 0.01, Figure 9B). In Non-Avoiders, a
relationship between these two variables was not significant (R2 = 0.29, p = 0.11, Figure
9B). These results suggest a more complicated interaction between dorsal and ventral
CRF cell population underlying avoidance behavior and can explain why group
differences in the percent of CRF cells activated were not detected statistically. No
significant differences were observed among treatment groups in the CRF, pERK, or
double-labeled cell density, and the mean fluorescent intensity of the CRF and pERK
immunolabeling (Table 2).
As shown in Table 2, the vmPFC contains a higher density of pERK positivelabeled cells (t(27) = -4.35, p < 0.001), lower density of CRF positive-labeled cells (t(27)
= 7.22, p < 0.001), and lower double-labeled cell density (t(27) = 9.88, p < 0.001) than
the dmPFC. The vmPFC had a lower percent of activated CRF cells than the dmPFC
(t(27) = 5.66, p < 0.001, Figure 9B). When different treatment and stress-reactive groups
were analyzed separately, the dorsal/ventral differences were more robust in stressed
animals than in control animals (Control, t(7) = 2.49, p < 0.05; Non-Avoider, t(9) = 3.94, p
< 0.01; Avoider, t(9) = 3.53, p < 0.01). Thus, stress history induces a prominent
differential activation pattern between dmPFC and vmPFC, which may be important for
responding to a context that has been previously paired with stress.
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Discussion
Individuals with mental health disorders such as post-traumatic stress disorder
often present symptoms of AUD as well. Co-morbidity suggests that the behavioral
symptomology may be driven by a common neural mechanism. The present study used
a rodent model of traumatic stress that has been shown to increase alcohol-drinking
behavior to test the hypothesis that the prefrontal CRF stress peptide system is
dysregulated in stress-vulnerable animals. Results indicate that predator odor stress
induces differential adaptive processes in CRF populations within the dmPFC versus the
vmPFC. Avoiders had slightly higher CRF cell density in the vmPFC compared to NonAvoiders and Controls, and higher CRF cell density correlated with more avoidance
behavior. Re-exposure to the context also resulted in opposing relationships between
avoidance levels and percent activated CRF cells in the two stressed groups. The data
altogether suggest that balance between CRF populations in the dmPFC and vmPFC
may determine stress reactivity and coping strategy among individuals.
The predator odor stress model was useful to screen a specific population that is
vulnerable to both stress and alcohol drinking. Although the place preference score after
odor exposure was not different between the non-odor-exposed control group and odorexposed stress group (including Non-avoiders and Avoiders), stressed animals did show
increased neuroendocrine responses during a re-exposure to the odor-paired context
(Whitaker and Gilpin, 2015). Animals with high avoidance level (Avoiders) show
phenotypes such as escalated drinking, compulsive drinking, and hyperalgesia, whereas
animals with low avoidance level (Non-avoiders) behave similarly as Controls (Edwards
et al., 2013, Igota et al. in submission). Thus, Non-Avoiders and Avoiders appear to
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comprise two distinct populations with different neural adaptation processes to the
predator odor stress.
This chapter demonstrated that predator odor stress induced a differential
adaptation in the CRF system of the mPFC between stress-resilient and stressvulnerable individuals. First, I found that predator odor stress slightly increased CRF cell
density in the vmPFC of Avoiders, but not in the dmPFC, CeA, dlBNST, and PVN. In
addition, avoidance of the odor-paired context positively predicted the CRF cell density
in the vmPFC of all stressed rats. Lack of this relationship in control rats (data not
shown) indicates that change in the CRF population of the vmPFC did not result from a
natural change in context preference, and further supports that the change in the CRF
cell density of the vmPFC was induced by odor stress. Second, differential activation of
CRF cells in the mPFC of Avoiders and Non-Avoiders may determine the dimension of
avoidance levels. In the vmPFC, Avoiders had a trend of higher percent-activated CRF
cells than Non-Avoiders, and there was a possible relationship between higher percentactivated CRF cells and more avoidance behavior. This result was in line with
Experiment 1 observation. In the dmPFC, Non-Avoiders and Avoiders had opposite
correlations between percent activated CRF cells and avoidance. This result suggests
that stress resilient and stress vulnerable individuals have differential adaptation
processes in the CRF system of the dmPFC and vmPFC, which may contribute to
behavioral differences in avoidance and alcohol drinking.
Increased vmPFC activity has been associated with heightened avoidance
behaviors. Animals expressing heightened avoidance behavior have increased pERK
protein level in the mPFC (Perrotti et al., 2013). Edwards et al. (2013) reported that
Avoiders have higher pERK levels than Non-Avoiders after odor-paired context re39

exposure (Edwards et al., 2013). In addition, high stress-reactive animals have
increased c-fos cell number in the vmPFC (Martinez et al., 2013). Here, I found that NonAvoiders and Avoiders had similar level of pERK cell number and labeling intensity in the
vmPFC after a re-exposure to odor-paired context. The inconsistency between the
current results and Edwards et al. (2013) finding may be due to the different detection
methods of the protein (immunohistochemistry versus western blot). In addition, rats in
the previous study have a more enriched history, including operant learning, alcohol
drinking, and one additional odor-paired context re-exposure. Pre-stress alcohol
exposure may sensitize rats’ stress reactivity, and post-stress alcohol exposure may
further potentiate the stress effect in the vmPFC.
Aversive stimuli can stimulate release of CRF in the mPFC (Merali et al., 2008). In
the second experiment of the current study, odor-paired context re-exposure presumably
activated CRF cells and trigger peptide release in the mPFC. Release of CRF could
decrease or even deplete CRF intracellular stores in CRF cells, which would reduce the
ability to detect these cells using immunohistochemistry. The context re-exposure was
15 minutes and experimental animals were euthanized 15 minutes after the end of the
re-exposure. It takes CRF cells 20-30 minutes to synthesis and package CRF peptide
into vesicles and another 30 minutes to transport those vesicles to terminals (Watts,
2005). Presumably the 30-minute period would be short enough to reveal activated CRF
cells with minimal effect on the peptidergic stores. Indeed, I found that a proportion of
CRF cells expressed pERK in both dmPFC and vmPFC. Thus, release of CRF did not
appear to have depleted CRF stores enough to alter CRF cell number in this experiment.
Nevertheless, Avoiders did not have higher CRF cell densities compared to NonAvoiders and Controls after odor-paired context re-exposure, which was inconsistent
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with the results from Experiment 1. CRF cell densities in the Experiment 1 were 1.5 to 2
fold higher than in Experiment 2. The discrepancy could be due to the different detection
substrates for hydrogen peroxidase. The chromogenic substrate (DAB) may have higher
reaction rates and may reveal more medium/low CRF-containing cells than the
fluorescent substrate (AmplifluTM Red). Therefore, 30 minutes after the onset of the
context exposure was likely sufficient to reveal activated CRF cells that express high
CRF levels. However, I cannot rule out that medium or low CRF-containing cells respond
to the context re-exposure but are not detectable using the current method.
Nine days after odor exposure, the CRF cell density in the dmPFC had a trend of a
positive relationship with avoidance. Together with no group differences in this CRF
population, these results suggest that dmPFC CRF population is a predisposing factor
underlying avoidance behavior. Interestingly, the activation pattern of these cells after
odor-paired context re-exposure showed a non-linear relationship with avoidance that
was similar to an inverted-U shape. Percent activated dmPFC CRF cells negatively
correlated with avoidance in Avoiders and there was a trend of a negative correlation
with preference for the odor-paired context in Non-Avoiders. Therefore, it is possible that
insufficient activation of the CRF cells in the dmPFC leads to excessive avoidance in
stress-sensitive animals or risky behavior in stress-resilient animals. An inverted-U
response curve has been reported in other stress responsive systems, such as
norepinephrine and dopamine in the prefrontal cortex (Arnsten, 2009). This type of
responsive curve is contributed by the level and/or composition of postsynaptic receptors.
For example, low levels of norepinephrine primarily activate its alpha2A receptors, and
excessive norepinephrine activates its alpha1 receptors. It is possible that the differential
CRF cell activation pattern between Non-Avoiders and Avoiders indicates different CRF
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receptor composition in the dmPFC, or the change at the receptor level after odor stress
may invert the effect of CRF release in the dmPFC. Individual differences in stressinduced adaptation upstream of CRF cells may also contribute to differential activation
patterns.
Conclusion
One-time predator odor stress induces prolonged behavioral phenotypes, including
blunted neuroendocrine stress responses, persistent avoidance behavior, and escalated
drinking. Results from this chapter suggest that CRF cell number in the vmPFC
contributes to stress vulnerability as a predisposing factor in Avoiders. Further
mechanisms, including differential activation of CRF cells between dorsal and ventral
mPFC in stressed animals, may be involved in not only stress vulnerability but also
stress coping mechanisms.

42

Figures and Tables

A
Acclimation CPA
(7 d)
(4 d)

Day 1
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{ Experiment 1: without context re-exposure
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OR
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Experiment 1
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Figure 6. Experimental timeline and avoidance levels on the day of post
conditioning test.
A. Experimental timeline. Rats were acclimated to the vivarium for a week before a 4day conditioned place aversion (CPA) procedure. Eight days after the procedure, rats
were euthanized with or without an odor-paired context re-exposure for 15 minutes. B.
Avoidance score during post conditioning test. Avoidance was the difference of the time
spent in the odor-paired context between day 4 (post conditioning) and day 1 (neutral
conditioning). Control rats were not exposed to predator odor. Stressed rats were
exposed to predator odor. Stressed rats with avoidance less or equal to -10 were termed
Avoiders. All other stressed rats were termed Non-avoiders. *, p < 0.01 when comparing
to control group. Behavioral studies were conducted by our collaborators in the
Louisiana State University Medical School, and the brains of these rats were analyzed at
University of Massachusetts Amherst.

43

A
mPFC
dmPFC

AC

vmPFC

PrL
IL

B

CRF cells per mm2

dmPFC

CRF cells per mm2

dmPFC

R2
Control

Avoider Avoider
High

vmPFC

Avoidance

Low

vmPFC

CRF cells per mm2

CRF cells per mm2

*

R2
Control

Avoider Avoider
High

44

Avoidance

Low

Figure 7. (Experiment 1) Slightly increased CRF cell number in the vmPFC 9 days
after the predator-odor stress.
A. Illustration of the anatomical location of tissue sections and subregions within the
mPFC that were sampled for analyses. The photomicrograph on the right showed a
sample of CRF immunolabeling in the mPFC. Scale bar, 100 µm. B. Avoiders had
significantly higher CRF cell density than Non-Avoiders and Controls in the vmPFC (*, p
< 0.01) but not in the dmPFC. CRF cell density positively correlated with avoidance in
the dmPFC and vmPFC (dmPFC, R2 = 0.18, p = 0.06; vmPFC, R2 = 0.37. p < 0.01). Bar
graphs were presented as mean plus standard error with individual data points. Control,
white color; Non-Avoiders, gray color; Avoiders, black color. n = 9-11 per treatment
group.
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Figure 8. (Experiment 1) Effects of predator odor stress on the CRF cells of the
CeA, dlBNST, and PVN.
(Left) Example photomicrographs showing CRF cells and fibers in the CeA (A), dlBNST
(B), and PVN (C). (Right) Quantification of CRF cell numbers in these three regions.
There were no group differences in the CeA, dlBNST and PVN in CRF cell number 8
days after the conditioned place aversion paradigm. Bar graphs were presented with
mean plus standard error, and gray circles depicted individual rats. Abbreviations: 3V,
third ventricle; BLA, basolateral nucleus of the amygdala; CeA, central nucleus of the
amygdala; CPu, caudate and putamen; dlBNST, dorsolateral portion of the bed nucleus
of the stria terminalis; LV, lateral ventricle; PVN, paraventricular nucleus of the
hypothalamus; ot, optic tract; ac, anterior commissure.
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High

Figure 9. (Experiment 2) Differential CRF activation 15-minute after re-exposure to
the odor-paired context.
A. Confocal fluorescence photomicrographs of pERK (green) and CRF (red) in the
dmPFC and vmPFC. CRF and pERK were more likely to colocalize in the dmPFC than in
the vmPFC (dmPFC versus vmPFC, paired t-test, t(29) = 5.61, p < 0.001). Scale bar, 50
µm. B. In the dmPFC, avoidance and % activated CRF cells positively correlated with
each other in Avoiders and negatively in Non-Avoiders (Avoiders, R2 = 0.64, p < 0.01;
Non-Avoiders, R2 = 0.29, p = 0.11). No group differences in the % activated CRF cell
numbers were observed in the dmPFC and vmPFC. Bar graphs were presented as
mean plus standard error with individual data points. Control, white color; Non-Avoiders,
gray color; Avoiders, black color. n = 8-10 per treatment group.
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Table 1. (Experiment 1) Correlational analysis between avoidance score and CRF
cell number in the central nucleus of the amygdala (CeA), dorsolateral division of
the bed nucleus of the stria terminalis (dlBNST), and paraventricular nucleus of
the hypothalamus (PVN).
Control (n=8)
CeA
dlBNST
PVN

R2=0.06 p= 0.50
R2=0.00 p= 0.94
R2=0.13, p=0.30

Stressed (Non-Avoider &
Avoider) (n=18-19)
R2=0.13, p=0.11
R2=0.17, p=0.07
R2=0.08, p=0.22

Table 2. (Experiment 2) CRF and pERK cell density and mean fluorescent intensity
in the dorsal and ventral portions of the mPFC after re-exposure to the odorpaired context. Data are presented as mean ± standard error.
Subregions Control
Non-Avoider Avoider
dmPFC
26.3 ± 4.10
24.0 ± 3.22
25.6 ± 2.73
vmPFC
13.0 ± 2.34
17.8 ± 2.93
13.7 ± 2.46
pERKb
dmPFC
77.7 ± 15.94
87.5 ± 18.78 81.4 ± 16.26
vmPFC
89.4 ± 18.83 108.6 ± 19.33 98.6 ± 14.91
CRF and dmPFC
20.5 ± 2.93
15.7 ± 1.78
19.2 ± 1.65
a
pERK
vmPFC
7.8 ± 1.44
5.4 ± 1.26
7.6 ± 1.23
Mean
CRF
dmPFC
48.2 ± 7.31
42.7 ± 5.46
44.8 ± 6.15
intensity
vmPFC
40.0 ± 4.83
47.2 ± 7.58
41.0 ± 5.85
(gray
pERK
dmPFC
40.7 ± 8.20
42.3 ± 5.90
42.6 ± 7.72
value)
vmPFC
51.4 ± 11.20
62.3 ± 11.72 56.7 ± 11.27
a
CRF: dmPFC > vmPFC, p < 0.001; bpERK: dmPFC < vmPFC, p < 0.001.
Cell
density
(cells/mm2)

Protein
CRFa
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CHAPTER 3
ADOLESCENT BINGE DRINKING AFFECTS CORTICOTROPIN-RELEASING
FACTOR PEPTIDE IN THE MEDIAL PREFRONTAL CORTEX OF
MALE AND FEMALE RATS
Abstract
Corticotropin-releasing factor (CRF) is a neuropeptide that governs the
neuroendocrine response to stress. This peptide also functions as a neuromodulator,
influencing neural activity of cells. The prefrontal cortex is important for regulating
emotions and behaviors; thus, CRF cells in this brain region could modulate local
circuitry and contribute to several symptoms of alcohol use disorder such as heightened
anxiety and excessive drinking. I hypothesize that adolescent alcohol upregulates
prefrontal CRF, producing hyperactivation of prefrontal circuitry and downstream
functions. The present study explored some predictions of this hypothesis using
behavioral and histological methods to determine the relationship between adolescent
alcohol drinking, CRF, and cellular activation in the prefrontal cortex. In addition, CRF
was examined in three subcortical structures involved in negative affect states and
stress response: the central nucleus of the amygdala (CeA), bed nucleus of the stria
terminalis (BNST), and paraventricular nucleus of the hypothalamus (PVN). Male and
female rats binge drank alcohol early in adolescence (postnatal days 28 to 42). At the
end of the two-week binge, brains were processed and prefrontal sections were
immunolabeled for CRF and Egr-1 (an index of cell activation and plasticity). Brain
sections from CeA, BNST, and PVN were labeled for CRF. In contrast to the proposed
hypothesis, I found that adolescent binge drinking did not increase, but instead slightly
decreased CRF labeling intensity in the prelimbic and infralimbic cortices (PrL and IL).
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CRF cell number was not altered by alcohol, suggesting that the observed decrease in
CRF labeling reflects a loss of CRF fiber coverage in these prefrontal subregions. A
significant decrease in CRF cell number was observed in the CeA but not in the BNST
and PVN after two-week binge drinking. Alcohol did not increase overall activity in the
mPFC as I had predicted; however, positive correlations between Egr-1 cell density and
CRF labeling intensity in the PrL and IL of the binge groups suggest that alcohol
changes the functional connectivity between CRF and other cells of the mPFC. These
findings indicate that binge drinking may change the role of CRF in modulating local cell
activation and mPFC circuitry in the adolescent brain. Whether this neuroadaptation
persists into adulthood remains to be determined.
Introduction
People who abuse alcohol early in adolescence are more likely to develop alcohol
use disorder (AUD) in adulthood (e.g. Hill et al., 2000; Dawson et al., 2008; Courtney
and Polich, 2009). Preclinical evidence using animal models shows that binge ethanol
exposure during early adolescence can increase some drinking behaviors in adulthood
(e.g., Gilpin et al., 2012; Alaux-Cantin et al., 2013). Adolescence is a period when the
prefrontal cortex rapidly matures and the related brain connections undergo another
wave of remodeling (Flores-Barrera et al., 2014; Thomases et al., 2014; Caballero et al.,
2014a; 2014b). This maturational process is essential for executive functions such as
regulation of emotions and behavior (Quirk and Beer, 2006; Butkovich et al., 2015;
Garcia-Garcia et al., 2015; Najt et al., 2015; Stolyarova and Izquierdo, 2015).
Consequently, binge drinking during this period may seed risk factors for future
substance abuse/dependence by interfering with maturation of neural circuitry and cell
activation in the prefrontal cortex.
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The stress peptide corticotropin-releasing factor (CRF) initiates a neuroendocrine
stress response when an individual encounters physiological or psychological stimuli.
Drinking alcohol activates the neuroendocrine stress system in both humans and rodents
(King et al., 2006; Richardson et al., 2008a). Specifically, alcohol directly stimulates CRF
release from hypothalamic cells (Li et al., 2005), and indirectly induces CRF release in
the central nucleus of the amygdala (Lam and Gianoulakis, 2011). Dysfunctional CRF
signaling has been closely associated with excessive drinking and increased anxiety
during alcohol withdrawal (Koob et al., 2014). Intensive research on the hypothalamus
and amygdala shows that a “hypo” responsive CRF system in the hypothalamus or a
“hyper” responsive CRF system in the central nucleus of the amygdala may contribute to
escalated drinking in animals that are dependent on or abusively using alcohol (e.g.
Funk et al., 2006; Richardson et al., 2008a; Li et al., 2011; Lowery-Gionta et al., 2012). It
is possible that upregulated CRF in the prefrontal cortex may also contribute to AUD
vulnerability but it presently unknown how alcohol impacts the CRF in this region in
developing animals.
Alcohol-preferring mice (C57BL/6J) have higher levels of frontal cortical CRF
peptide than alcohol non-preferring mice (C3H/CRGL/2) (George et al., 1990). This
result suggests that increased frontal CRF may be a contributing factor to increased
alcohol drinking. A recent report shows that five months of intermittent drinking lead to
an increase in CRF-immunoreactive cells and cell activation, as indexed by the
immediate early gene Fos, in the mPFC during abstinence (George et al., 2012).
Interestingly, the increase in immunolabeled CRF cell number and mPFC activity is
reversed after two hours of alcohol drinking (George et al., 2012). These results suggest
that prefrontal cells, particularly CRF cells, are upregulated after chronic intermittent
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alcohol exposure and that acute alcohol consumption “normalizes” peptide cells in adult
male rats.
Considering the findings discussed above together with the fact that the prefrontal
cortex is highly plastic during adolescence, it is conceivable that adolescent drinking may
cause significant changes in the CRF system in the mPFC. Moreover, most of the
studies have been conducted in males; the effect of adolescent binge drinking on
females remains unclear. Thus another goal of this study was to include both sexes to
gain a full understanding of how alcohol affects the mPFC. I used a voluntary drinking
model to examine the effect of adolescent binge drinking on local cell activation and CRF
in the mPFC of male and female rats. CRF cell number was also quantified in the CeA,
BNST, and PVN. In addition, Egr-1 was accessed in the mPFC. Egr-1 was used as an
activity marker because this immediate early gene responds to activation of glutamate
receptors and has high expression at basal levels (Beckmann and Wilce, 1997;
Herdegen and Leah, 1998; Knapska and Kaczmarek, 2004). Adolescent binge exposure
to alcohol slightly increases Egr-1 expression in the subregions of the mPFC at basal
levels in adulthood (Liu and Crews, 2015). Thus, change of Egr-1 at protein level can be
an index of changes in neural activity after two-week binge treatment. It was predicted
that adolescent binge drinking would increase CRF, and this would correlate with
increased cortical activation in the mPFC. Additionally, I predicted that a binge level of
alcohol intake, i.e. producing alcohol levels of 0.08 g/dL or higher, would be necessary to
induce a significant change in CRF.
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Materials and Methods
Animals
Sixty-nine adolescent Wistar rats (Charles River, 35 males and 34 females) arrived
on postnatal (PD) 18 with dams, and were weaned on PD21. They were housed in
same-sex groups of three in plastic cages with wood chip bedding under a 12-hour
light/dark cycle (lights on at 8 a.m.). Animals had ad libitum access to food and water
throughout the experimental period. During this period, rats were handled and weighed
daily. All procedures met the guidelines of the Institutional Animal Care and Use
Committee as well as of the National Institutes of Health Guide for the Care and Use of
Laboratory Animals. Animal numbers in each treatment group were 14 control males, 14
control females, 14 binge males, 13 binge females, 7 capped non-binge males, and 7
capped non-binge females.
Operant training
Adolescent male and female rats were trained to self-administer sweetened water
(3% glucose and 0.125% saccharin in tap water) from postnatal day (PD) 22 to 27 during
the dark phase of the light/dark cycle (Karanikas et al., 2013). Animals were trained to
lever press using a two-lever training protocol. Each training bout was five minutes with
either one or two levers, and the available lever was randomized in each bout (right lever,
left lever, or both). Lever presses activated a cue light and resulted in the delivery of 0.1
mL of reward solution. On the first day of training, rats were trained in groups of three.
On the second and third days of training, rats were trained in pairs. On the fourth and
fifth days of training, rats were trained individually. On the last day of training, rats were
tested using the binge protocol (see below) with sweetened water. The group
assignment was balanced by lever pressing for the sweetened water reward using data
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from the last training day. Food and water were available ad libitum during the training
and binge sessions.
Two-week binge period
From PD28 to PD42, control animals continued to lever press for sweetened water
(Figure 10A). Binge and non-binge (capped) alcohol animals lever pressed for
sweetened alcohol (8-10% w/v ethanol in sweetened water). The binge protocol
consisted of six 30-minute bouts at 60-minute inter-bout-intervals with only the right lever.
The total glucose intake was monitored daily, and the number of available lever presses
in control animals was adjusted in order to maintain comparable total glucose intake with
alcohol drinking groups. The lever was retracted after the capped number of responses
was reached or at the end of a 30-minute bout. The cap number for binge and non-binge
(capped) animals was determined by an estimate of 4.54 g/kg and 0.5 g/kg alcohol
intake, respectively. The number of lever presses, received rewards, and the response
time were recorded via a computer connected to the operant boxes.
Perfusion and brain tissue sections processing
At the beginning of the light cycle, which was four to seven hours after the last
drinking bout, animals were deeply anesthetized and intracardially perfused with 4%
paraformaldehyde in 0.1M borate buffer, pH 9.5. Brains were post-fixed in the same
fixative for 4 hours at 4ºC and submerged in 20% sucrose in 0.1M phosphate buffer, pH
7.4 (PBS) for 48 to 72 hours before being snap-frozen in isopentane (2-methylbutane,
Fisher Scientific) as previously described (Richardson et al., 2006). Frozen brains were
stored at -80ºC until slicing into 35 µm coronal sections on a freezing microtome. Sliced
sections were stored in cryoprotectant (30% ethylene glycol, 30% sucrose, and 1%
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polyvinylpyrrolidone in 0.1M phosphate-buffered saline) at -20ºC before further
processing.
Brain sampling
The Rat Brain in Stereotaxic Coordinates Atlas was used as an anatomical
reference (Paxinos and Watson, 2007). The sampling area for mPFC was 3.72 mm to
2.52 mm from Bregma for serial sections spaced 350 µm apart. Subdivisions including
the anterior cingulate cortex (AC), prelimbic cortex (PrL), and infralimbic cortex (IL) were
defined using the corpus callosum (forceps minor) as an anatomical marker. The
sampling area for the CeA was -2.16 mm to -3.24 mm from Bregma for serial sections
spaced 175 µm apart, and for the BNST was 0.00 mm to -0.36 mm from Bregma for
serial sections spaced 175 µm apart.
Immunohistochemistry
Brain sections of interest were sorted out from cryoprotectant. The extra
cryoprotectant was removed by rinsing with PBS for five five-minute rinses. Further
rinses with Triton X-100 containing PBS (PBST; 0.3% Triton X-100 in 0.1M PBS, pH7.4)
were used to make the cell membrane finely porous. A 30-minute 3% hydrogen peroxide
(H2O2 in PBS) incubation to eliminate the endogenous peroxidase activity was followed
by a blocking step of a one-hour incubation with 5% non-fat milk in PBS. Rabbit anti h/r
CRF antiserum (1:20,000, gift from Dr. Paul Sawchenko at the Salk Institute, La Jolla,
CA) or rabbit anti Egr-1 (1:5000, Santa Cruz) was prepared in 5% non-fat milk and 10%
normal goat serum in PBST. The primary antisera were incubated for 16 to 18 hours at
4ºC. After further PBST rinses, brain sections were incubated with biotinylated goat anti
rabbit IgG antiserum (1:200, Vector Laboratories) in PBS for two hours at room
temperature. Streptavidin conjugated horseradish peroxidase (HRP) was applied for 1
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hour at room temperature. The chemical substrate for peroxidase, 3,3’-diaminobenzidine
(DAB, Vector Laboratories) with nickel was used for the final color reaction. After
immunolabeling, the sections were mounted on gelatin-coated glass slides, dehydrated
and cleared before coverslipping. The dehydration and clearing process included 2
minutes in 70% ethanol, 2 minutes in 95% ethanol, two 2-minute rinses in 100% ethanol
and three 5-minute rinses in xylene. Slides were then coverslipped with DPX mounting
media (Sigma-Aldrich) for microscopic analysis.
Quantification of CRF cells in the BNST and CeA
BNST sections were identified using anterior commissure as the anatomical
marker. Three sections (175 µm apart from each other, Karanikas et al., 2013)
containing CRF labeled cells were collected together as representing the CRF population
in the BNST. Five CeA sections (175 µm apart from each other, Karanikas et al., 2013)
containing CRF labeled cells were collected together as representing the CRF population
in the CeA. An experimenter blinded to the treatment of the animal counted cell
expressing CRF peptide using a Nikon microscope at 400x magnification (40x objective
and 10x eyepiece) and a standard thumb-operated tally counter. Cells containing
labeling throughout the soma and neuronal processes, with a clear border around the
soma were considered CRF-immunoreactive (CRF-ir) and counted as described above.
Adjusting the optical axis (z-axis) of the microscope allowed for clearer visualization of
the depth of the soma to better distinguish the soma from a CRF-ir cell versus any
ambiguous particle on the section. Also, adjusting the z-axis allowed for clearer
visualization of individual cell borders when cells were clustered together (Gilpin et al.,
2012).
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CRF intensity measurement
Photomicrographs of CRF immunolabeling in the subdivisions of the mPFC were
taken under 20X objective using a Leica microscope attached to a DP71 Olympus
camera. Individual photomicrographs covered areas from cortical layers II to VI. All
images were taken under the same microscopic settings. The light intensity was finely
adjusted for each cohort of animals to produce comparable background signal in all
samples. Photomicrographs were analyzed using the ImageJ software package
(Rasband, 1997). Colored digital images were converted into 8-bit, inverted, and
calibrated with the proper scale unit. Background signal was generated using a
Gaussian filter with a diameter of 7.5 µm for each image, and this was subtracted. The
mean of all background subtracted images plus three standard deviations was used as
the threshold for % covered area measurement. This intensity measurement consisted of
both CRF soma and fibers.
CRF cell counts
Slides containing mPFC sections were digitally scanned at resolution (20X) under
bright field illumination by Aperio ePathology (Leica Biosystems). Two sections (350 µm
apart from each other) containing CRF immunoreactive (CRF-ir) cells were used as a
representative of the CRF population in the mPFC. Subdivisions including the AC, PrL,
and IL were defined as described in the Brain sampling section. Given this distance in
sampling my interval and the fact that CRF cells are less than 10 µm in diameter and
rarely overlap with one another in the mPFC, it is unlikely that I would double count cells
in my studies. Nevertheless, to avoid biased sampling, I counted all CRF cells in the
mPFC rather than sampling small areas within the mPFC to estimate the number of cells
in that slice. Each subdivision was traced and measured in ImageScope software (Leica
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Biosystems). Experimenters blind to the treatment groups counted CRF-ir cells under
10X magnification of the slide images. The criteria for identifying CRF-ir cells were a
clearly defined border of the soma and some extended neurites.
Egr-1 cell counts
Photomicrographs were obtained with consistent parameters across all animals
using a 20X objective on a Leica microscope attached to a DP71 Olympus camera.
ImageJ software was used for the following analysis procedure (Rasband, 1997). All
digital images were converted to 8-bit, inverted, and then threshold was set using the
Maximum Entropy algorithm by selecting an Egr-1 positive cell with medium-labeled
intensity. This selection method defined all cells with high-labeled intensity and most of
the cells with medium-labeled intensity without highlighting cells with low-labeled
intensity. The Analyze Particles function was used to quantify the number of Egr-1
positive cells. The parameters for defining a cell were 200-1000 pixels (30-150 µm2) for
size and 0.6-1.0 for circularity. The defined cells were confirmed by overlay outlines on
the original images. The watershed function was not applied in order to avoid falsepositive cell counts. An average number across hemispheres and sections was used to
represent the number of Egr-1 positive cells in each animal.
Statistical analysis
The normality and differences in variances of each measurement were examined
using a Shapiro-Wilk normality test and an F test, respectively. If the normality or equal
variance was violated, the measurement was analyzed using a non-parametric MannWhitney U test. The CRF labeling intensity and CRF cell density in each subregion of the
mPFC were analyzed using a two-way ANOVA with treatment and sex as betweengroup variables. Whenever the interaction between treatment and sex was not significant,
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the interaction term was removed from the analysis. Further group comparisons were
done using a pairwise t-test with Bonferroni p-value correction. The Egr-1 cell density
was not normally distributed in the IL (AC, W = 0.945, p = 0.07; PrL, W = 0.955, p =
0.15; IL, W = 0.935, p = 0.04). In order to be consistent in the Egr-1 analysis, the group
or sex differences from all three subregions were examined using a Mann-Whitney U
test. Pearson’s correlation was used to analyze the relationship between two
measurements. Differences were considered significant when p ≤ 0.05. Data were
expressed by mean ± standard error of the mean (SEM) with individual data points. All
statistical analyses were conducted using the R statistical software package (R Core
Team, 2014).
Results
Adolescent binge drinking decreased CRF cell number in the CeA
After a two-week binge exposure, there was a subtle but significant treatment
effect in the CRF cell number in the CeA of binge rats (Figure 11A, treatment effect,
F(1,29) = 6.82, p = 0.01; sex effect, F(1,29) = 2.44, p = 0.13; updated results from
Karanikas et al., 2013). No treatment effect was observed in the CRF cell number in the
dlBNST and PVN (Figure 11 B&C, all ps > 0.05). Significant relationships between
alcohol intake and CRF cell number were found in the dlBNST and PVN, which was
positive in the dlBNST and negative in the PVN (Figure 11 B&C and Table 4).
Adolescent binge drinking slightly decreased CRF immunoreactivity in the mPFC
To examine the effect of adolescent binge drinking on the CRF system in the
mPFC, adolescent rats were trained to voluntarily drink sweetened water or sweetened
alcohol in operant boxes. The average daily intake of glucose was not significantly
different between treatments and sexes (Figure 10B, left, all p > 0.05). In the binge
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group, males and females had a similar amount of average daily alcohol intake (Figure
10B, right, t(51.5) = 0.39, p = 0.70). In addition, alcohol treatment did not have an effect
on animals’ body weight (Table 3, Treatment, p > 0.05).
When the adolescent binge effect was compared in both males and females
together, I found that binge drinking during this period significantly decreased CRF
immunoreactivity in the PrL and IL but not in the AC (Figure 12B, AC, F(1,52) = 2.29, p =
0.14; PrL, F(1,52) = 5.59, p = 0.02; IL, F(1,52) = 6.85, p = 0.01). No sex differences were
observed (all p’s > 0.05). The overall immunoreactivity consisted of both CRF fibers and
CRF soma. To distinguish whether the decrease was a result of the loss of fibers or
soma, I quantified CRF cell number and found no sex or treatment effect when
comparing control and binge groups (Table 5, all p’s > 0.05). Thus, the decrease of CRF
immunoreactivity was likely reflecting the decrease in CRF fiber coverage in the PrL and
IL.
As CRF modulates cellular activity (Gallopin et al., 2006; Liu et al., 2015), it was
hypothesized that the observed decrease in CRF would correspond with a decrease in
regional cellular activity. Using Egr-1 as an activity marker, I investigated the effect of
adolescent binge drinking on Egr-1 cell density and the relationship between Egr-1 and
CRF in the subregions of the mPFC. First, I found no significant treatment effect on Egr1 cell density (all p’s > 0.05). Instead, a trend of a sex difference was observed in the AC
and PrL but not in the IL (Figure 12C, bottom panel, AC, W = 105, p = 0.06; PrL, W =
104, p = 0.07; IL, W = 86, p = 0.44). The trend of females having more Egr-1 cells in this
study is consistent with my previous observation in naïve adolescent rats (Chapter 4,
Figure 18). The decrease in the CRF of the PrL and IL did not correspond with local cell
activation, at least when Egr-1 was used as an activity marker. Second, I found
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interesting correlations between Egr-1 and CRF among subregions of the mPFC. In the
AC, there was a positive relationship between CRF labeling intensity and Egr-1 cell
density, and drinking alcohol weakened this relationship (Figure 13, AC, control, R2 =
0.53, p < 0.01; binge, R2 = 0.08, p = 0.43). In the IL, a positive correlation between CRF
labeling intensity and Egr-1 cell density was found in the binge but not in the control
group (Figure 13, control, R2 = 0.04, p = 0.52; binge, R2 = 0.55, p = 0.01). In the PrL, no
correlation between CRF labeling intensity and Egr-1 cell density was observed in either
control or binge groups (Figure 13, control, R2 = 0.01, p = 0.77; binge, R2 = 0.07, p =
0.46). In addition, positive correlations were only found between CRF cell density and
Egr-1 cell density in the PrL and IL of alcohol animals (Table 6). The complex
relationship among mPFC subregions may be due to the different functionality of these
regions.
Individual differences in alcohol intake did not relate to CRF measurements in the
mPFC but did relate to cell activation in the AC.
To examine whether alcohol consumption or numbers of binge exposure
(estimated blood alcohol level over 0.08 g/dL) would affect the CRF or Egr-1 cell number,
I tested the correlations between these parameters. The relationship between these
parameters is summarized in Table 7 for CRF labeling intensity, Table 8 for CRF cell
density, and Table 9 for Egr-1 cell density. Total alcohol intake positively correlated with
Egr-1 cell density in the AC (Table 9, R2 = 0.49, p = 0.02). No other relationships were
observed between drinking and CRF or Egr-1.
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Non-binge alcohol intake was insufficient to decrease CRF immunoreactivity in
the mPFC
I analyzed two components of alcohol drinking behavior: average daily alcohol
intake (g/kg/day) and the total number of “binges.” The number of binges was estimated
by counting the total number times over the two-week treatment period in which animals
consumed at least 1.25 g/kg of alcohol in a single 30 min self-administration bout. This is
an estimate of the amount of alcohol necessary to produce blood alcohol levels of 0.08
g/dL or higher (Walker et al., 2008; Gilpin et al., 2012; Broadwater et al., 2013; Doherty
and Gonzales, 2015). To distinguish whether binge-like intake was necessary for altering
CRF, I included a non-binge comparison group in the experimental design. This group
was called “low non-binge alcohol” and these animals were allowed to self-administer
alcohol throughout the two-week treatment period but the maximum number of lever
presses was “capped” so they could not consume > 0.5 g/kg in a single selfadministration session. By limiting intake in this group, I could ensure blood alcohol
levels would not reach 0.08 g/dL for any sessions, while maintaining average daily
alcohol intake comparable to that consumed by a subset of binge animals (“low binge
alcohol,” Figure 14). An additional control group (“low control”) was also included in the
design. In this control group, sweetened solution intake was limited to match that of low
non-binge alcohol and low binge alcohol groups (low control, Figure 14A). ANOVA
analyses showed a significant difference among the three groups in the PrL and a trend
of differences in the IL (Figure 14 E&F, PrL, F(2,37) = 4.12, p = 0.02; IL, F(2,37) = 2.91,
p = 0.07). No significant sex differences were observed (all p’s > 0.05). A pairwise t-test
using Bonferroni correction showed that low binge alcohol animals had a significantly
lower CRF immunoreactivity than low control animals in the PrL (p = 0.02). A similar
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trend was found in the IL (p = 0.07). CRF immunoreactivity was not significantly reduced
in the low non-binge alcohol group compared to the low alcohol control (p > 0.05).
Discussion
Adolescent binge drinking is associated with an increased risk of alcohol use
disorder (AUD) in humans (Hingson et al., 2006; Carvajal and Lerma-Cabrera, 2015).
Studies using animal models suggest that alcohol exposure may alter the development
of brain circuits during adolescence to increase the risk of AUD in adulthood, e.g., Gilpin
et al., 2012; Alaux-Cantin et al., 2013; Gass et al., 2014. The goal of the present study
was to investigate the effect of alcohol on the CRF stress peptide system in the mPFC. I
hypothesized that adolescent binge drinking upregulates the CRF system in the mPFC
because these cells are positioned to modulate the activity of prefrontal circuits involved
in behavioral control. Contrary to my predictions, I found that alcohol had the opposite
effect on this peptide system. Adolescent binge drinking—but not non-binge drinking—
decreased CRF labeling intensity in the PrL and IL. This effect was not observed in the
AC. Alcohol did not significantly change the number of CRF-labeled cells, suggesting
that the decrease in CRF labeling intensity reflects reduced CRF fiber/axon terminal
coverage and/or CRF release into the mPFC. A decrease in CRF cells in the CeA
suggests that adolescent binge drinking attenuates CRF in both cortical and subcortical
brain regions. In addition, high drinking behavior related to more CRF cells in the
dlBNST but fewer CRF cells in the PVN. This suggests that if alcohol alters these cell
populations it does so in opposite directions and in a dose-dependent manner.
Alternatively CRF cell populations in the dlBNST and PVN may differ in individuals
predisposed to heavy drinking prior to alcohol exposure. The positive correlations
between CRF and Egr-1 in the PrL and IL of the binge group suggest that binge drinking
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alcohol may increase CRF’s influence on local cell activation. Altogether these findings
suggest that adolescent binge drinking alters prefrontal CRF cells, which may influence
local cell activation in the PrL and IL and further impact prefrontal cortex-mediated
behavioral control. How long these changes last are yet to be determined.
CRF labeling intensity was reduced in the PrL and IL at the end of the two-week
binge-drinking period in adolescent rats. George et al. (2012) reported that CRF cell
number decreases after a two-hour drinking period in adult male rats that are chronic
abusive drinkers. One interpretation of the George et al. (2012) findings is that CRF cells
in the mPFC react to acute alcohol exposure by releasing CRF. These cells may not be
detected by immunolabeling because peptide stores have not yet been replenished
when the brains were processed. In the present study, brains were processed four-toseven hours after the last access to alcohol self-administration. It is therefore possible
that the decrease in CRF labeling intensity reflects an acute effect of alcohol drinking on
this population of cells rather than a long-term change in this peptide brought on by
chronic alcohol exposure. However, the amount of alcohol intake in the last bout did not
predict either CRF cell number or CRF labeling intensity in the mPFC subregions (data
not shown). When comparing CRF-related measurements between rats that drank or did
not drink in the last bout, I found no differences between these two conditions (data not
shown). Therefore, the decrease of CRF labeling intensity more likely reflects a
neuroadaptive change in CRF circuitry in the PrL and IL that was brought about by two
weeks of binge alcohol exposure during early adolescence.
The decrease in CRF may be accompanied by an increase in CRF1 receptors
(CRFR1) quantity and or sensitivity in the PrL and IL. It has been reported that increased
CRFR1 quantity/sensitivity in the brain leads to increased drinking. Systemic injection of
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CRFR1 antagonists is sufficient to reduce alcohol drinking in alcohol-dependent animals
(Funk et al., 2007; Richardson et al., 2008b; Cippitelli et al., 2012). In particular, the
central nucleus of the amygdala (CeA) is a well-known brain region that has sensitized
CRFR1 and reduced CRF in high drinking animals. Blockade of CRFR1 in the CeA is
sufficient to reduce drinking in alcohol-dependent rats and binge-drinking mice but has
no effect on control animals (Funk et al., 2006; Lowery-Gionta et al., 2012). The
increased sensitivity of CRFR1 corresponds with a decreased CRF labeling intensity in
the CeA of the same dependent animals (Funk et al., 2006). Decreased CRF labeling
intensity has also been observed in animals with a history of adolescent binge drinking
(Gilpin et al., 2012; Karanikas et al., 2013). It is possible that the decrease of CRF
labeling intensity in the PrL and IL may correspond with increased sensitivity of CRFR1
in postsynaptic cells. Further examination of CRF and sensitivity to CRFR1 antagonists
could help clarify how CRF/CRFR1 signaling may differ after adolescent experience with
alcohol.
Adolescent binge alcohol exposure leads to several prefrontal-related behavioral
deficits in adulthood. Adult animals with a history of alcohol exposure in adolescence
show increased alcohol drinking, impulsivity, reduced behavioral flexibility, and impaired
reversal and extinction learning (Gilpin et al., 2012; Vetreno and Crews, 2012; AlauxCantin et al., 2013; Boutros et al., 2014; Gass et al., 2014). These adult behavioral
phenotypes correspond to changes in the expression of immediate early genes at
baseline level. For example, alcohol-treated animals have an increase in Egr-1 cells,
which reflects glutamate receptor-mediated neuronal plasticity (Worley et al., 1991;
Beckmann and Wilce, 1997; Herdegen and Leah, 1998; Liu and Crews, 2015). It is less
clear whether these changes occur immediately after adolescent binge drinking, or if a
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period of abstinence between adolescent alcohol treatment and adulthood is essential to
develop these behavioral and neuronal phenotypes. My data suggest that under
baseline/basal conditions, Egr-1 cell numbers were not affected immediately after the
two-week binge period. In addition, rats with the highest level of alcohol intake early in
adolescence did not show deficits in prefrontal-mediated behavior as measured by the
delayed spontaneous alternation in T-maze task until adulthood (Vargas et al., 2014).
These results suggest that developmental changes during late adolescence and/or a
sustained abstinence period may be necessary to amplify the effect of early adolescent
binge drinking on prefrontal-dependent functions.
Substance abuse changes CRF function in the mPFC. Orozco-Cabal et al. (2008)
reported that chronic cocaine exposure inverts the synergistic effect of CRF on
dopamine from inhibitory to excitatory in the mPFC (Orozco-Cabal et al., 2008). Another
functional change in CRF signaling after chronic alcohol exposure has also been
reported from the cells of the bed nucleus of the stria terminalis that project to the ventral
tegmental area. CRF enhances presynaptic glutamate transmission in naïve animals,
whereas this effect is occluded in the acute withdrawal from chronic alcohol exposure
(Silberman et al., 2013). In this chapter, correlations between CRF measurements and
cell activity marker, Egr-1, have shown how adolescent alcohol exposure might modify
CRF’s function on downstream cell activation. In the IL, CRF labeling intensity and cell
number positively correlated with Egr-1 cell density in the binge but not in the control
groups. I also observed similar results in the PrL when examining CRF cell density and
Egr-1 cell density, whereas no correlation was observed between CRF labeling intensity
and Egr-1 cell density in the PrL in both control and binge groups. In the cortex, CRF
reduces the afterhyperpolarization currents and makes postsynaptic cells more excitable
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through CRFR1 (Hu et al., 2011). Thus, the positive correlation between CRF and Egr-1
in the binge group may further indicate that CRFR1s are upregulated in the PrL and IL
after two weeks of binge drinking.
In addition to the age of onset of drinking being a risk factor for AUD, a short
progression from alcohol drinking to binge intoxication in adolescence is another risk
factor for heavy alcohol use later in adulthood (Morean et al., 2014). Repetitive exposure
to binge levels of alcohol, i.e. producing 0.08 g/dL or higher levels of alcohol in the blood,
can produce strong and potentially irreversible impact on developing adolescent brains
(Spear and Swartzwelder, 2014; Spear, 2015). However, the importance of “binge” in the
effects of adolescent alcohol on the brain—especially voluntarily consumed alcohol—has
not been closely studied. To further examine whether binge drinking was essential to
inducing the change in CRF in the PrL and IL after early adolescent alcohol exposure,
intake was capped to produce a low non-binge group. Analyses showed that the low
non-binge group still had lower CRF labeling intensity than the low control group in the
PrL and IL, but the CRF labeling intensity in the non-binge group was between that of
the low control and low binge groups. These results suggest that non-binge alcohol
drinking has little-to-no effect on CRF versus the same amount of total alcohol exposure
consumed through binge alcohol drinking. Thus, binge-like consumption appears to
exacerbate the effect of alcohol on CRF cells in the mPFC under conditions where total
alcohol intake is equivalent.
Conclusion
Adolescent binge drinking increases the risk of adult alcohol use disorder. Using
an adolescent voluntary drinking model, I found a decrease in CRF levels in the
prelimbic and infralimbic cortices, and this effect may be a risk factor for future alcohol
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misuse. The correlation between CRF and local cell activation in the binge group but not
in the control group suggests that CRF increases its influence on regional activity after
alcohol exposure. Future studies will focus on other aspects of the CRF system in the
mPFC, such as CRF cell excitability in response to alcohol and CRF receptor levels and
receptor-conjugated G protein signaling, to further establish CRF-related vulnerability to
alcohol use disorder.
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Figure 10. Experimental timeline and average glucose and alcohol intake between
control and binge groups.
A. Experimental timeline. Animals arrived on postnatal day (PD) 18 with dams and
weaned on PD21. Operant training was carried out from PD22 to PD27 using sweetened
water. Binge period started from PD28 and continued until PD42. Voluntary drinking
started at the beginning of the dark phase of the light/dark cycle. Each drinking cycle
contained eight 30-min bouts with 1 hr inter bout intervals. Four to seven hours after the
last binge bout, rats were euthanized using transcardiac perfusion. B. (Left) Male and
female adolescent rats had similar levels of glucose average daily intake in control and
binge groups. (Right) No significant differences were observed in average daily alcohol
intake between male and female rats in the binge group. n = 13-14 per group/sex.
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Figure 11. Effects of adolescent binge drinking on CRF populations in the CeA,
dlBNST, and PVN.
A. Alcohol animals had fewer CRF cells than control animals in the CeA. No
relationships were observed between CeA CRF cell number and alcohol intake or binge
number. B. No treatment or sex difference was observed in the dlBNST. However, a
strong positive correlation was detected between dlBNST CRF cell number and total
alcohol intake and total binge number. C. No treatment or sex difference was observed
in the PVN. Interestingly, a negative correlation was detected between PVN CRF cell
number and total alcohol intake and total binge number. *, p < 0.05. n = 7-9 per
group/sex.
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Figure 12. Two-week binge drinking decreased CRF immunoreactivity in the PrL
and IL without altering regional activity in the mPFC.
A. Illustration of sampled mPFC subregions and photomicrographs for CRF and Egr-1.
Adjacent sections from the same animals were used for CRF and Egr-1 immunolabeling.
B. Binge animals had significant lower CRF immunoreactivity (ir) than control animals in
the PrL and IL. No sex differences were detected. C. Females had a trend of higher Egr1 cell number in the AC and PrL (p=0.05 and p=0.09, respectively). No treatment
differences were detected. *, p < 0.05. For CRF labeling intensity measurement, n = 1314 per group/sex; for Egr-1 cell density, n = 5-6 per group/sex.
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Figure 13. Differential relationship between CRF immunoreactivity and Egr-1 cell
number in the subregions of the mPFC.
Figure 13. Correlation between CRF immunoreactivity and Egr-1 cell number in control
(top) and binge animals (bottom). CRF immunoreactivity positively correlated with Egr-1
cell number in the AC of control animals but not in the binge animals. No correlation was
detected in the PrL of control and binge animals. In the IL, a positive correlation was
found in binge animals but not in control animals.
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Figure 14. Low non-binge alcohol exposure had moderate or no effect on CRF
labeling intensity in the subregions of the mPFC in adolescent males and female
rats.
(A-C) Low control, low binge alcohol, and low non-binge alcohol (capped) groups had
similar levels of average daily glucose intake. Low binge and non-binge alcohol groups
had similar average daily alcohol intake but the capped groups were prevented from
experiencing binge intoxication throughout the two-week drinking period. (D-F) Low
binge group had significantly lower CRF immunoreactivity than low control group in the
PrL. A trend of decrease in the CRF immunoreactivity in the IL was also observed. No
statistical differences were detected between low binge and non-binge low alcohol
groups. *, p < 0.05 when low alcohol group was compared to low control group. n = 6-7
per group/sex.
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Table 3. Mean (±SEM) body weight (in g) on postnatal days 28, 35, and 42 in
alcohol and control male and female Wistar rats.
Control males
Binge males
Control females
Binge females

PD28
99.1 ± 3.80
98.2 ± 3.43
97.1 ± 3.22
93.4 ± 4.25

PD35
158.6 ± 6.06
159.4 ± 4.26
145.8 ± 4.33
140.8 ± 4.10

PD42
212.8 ± 8.67
218.3 ± 5.09
180.6 ± 5.48
172.9 ± 3.06

Table 4. Relationship between solution intake and CRF cell number in the dlBNST,
CeA, and PVN after the two-week binge period.

CeA
dlBNST
PVN

Control, n = 13-14
(total glucose
intake, g/kg)
R2=0.25, p=0.06
R2=0.02, p=0.58
R2=0.04, p=0.44

Alcohol, n = 14-15
(total alcohol
intake, g/kg)
R2=0.04, p=0.42
R2=0.42, p<0.01
R2=0.27, p<0.05

Alcohol, n = 14-15
(total binge number)
R2=0.07, p=0.29
R2=0.55, p<0.01
R2=0.23, p<0.05

Table 5. CRF cell density in the subregions of the mPFC after two-week binge
drinking.
Control males
Binge males
Control females
Binge females

AC
41.4 ± 1.89
43.0 ± 1.61
43.1 ± 1.69
40.8 ± 1.68

PrL
48.0 ± 1.55
48.9 ± 1.53
49.4 ± 1.70
47.8 ± 1.52

IL
52.9 ± 1.52
54.6 ± 1.46
54.0 ± 1.66
55.3 ± 1.43

Table 6. Relationship between CRF cell density and Egr-1 cell density in the
subregions of the mPFC.
AC
PrL
IL

Control (n = 12)
R2=0.10, p=0.28
R2=0.08, p=0.31
R2=0.00, p=0.87

Alcohol (n = 8)
R2=0.10, p=0.39
R2=0.46, p=0.03
R2=0.46, p=0.03

Table 7. Relationship between solution intake and CRF cell density after the twoweek binge period.

AC
PrL
IL

Control (n=14)
(total glucose
intake, g/kg)
R2=0.03, p=0.51
R2=0.01, p=0.70
R2=0.09, p=0.26

Alcohol (n=15)
(total alcohol
intake, g/kg)
R2=0.00, p=0.84
R2=0.01, p=0.73
R2=0.01, p=0.65

Alcohol (n=15)
(total binge number)
R2=0.00, p=0.98
R2=0.00, p=0.99
R2=0.14, p=0.14
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Table 8. Relationship between solution intake and CRF labeling intensity after the
two-week binge period.

AC
PrL
IL

Control (n = 26)
(total glucose
intake, g/kg)
R2=0.12, p=0.07
R2=0.12, p=0.08
R2=0.14, p=0.05

Alcohol (n = 25)
(total alcohol
intake, g/kg)
R2=0.09, p=0.13
R2=0.05, p=0.25
R2=0.07, p=0.19

Alcohol (n = 25)
(total binge number)
R2=0.07, p=0.17
R2=0.13, p=0.06
R2=0.10, p=0.10

Table 9. Relationship between solution intake and Egr-1 cell density after the twoweek binge period.

AC
PrL
IL

Control (n = 12)
(total glucose
intake, g/kg)
R2=0.23, p=0.08
R2=0.08, p=0.32
R2=0.06, p=0.41

Alcohol (n = 8)
(total alcohol
intake, g/kg)
R2=0.49, p=0.02
R2=0.28 p=0.11
R2=0.12, p=0.33

Alcohol (n = 8)
(total binge number)
R2=0.26, p=0.13
R2=0.20, p=0.19
R2=0.22, p=0.17
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CHAPTER 4
NEUROANATOMICAL CHARACTERIZATION OF CORTICOTROPIN-RELEASING
FACTOR SYSTEM IN THE MEDIAL PREFRONTAL CORTEX OF
ADOLESCENT MALE AND FEMALE RATS
Abstract
Sex differences in stress-related disorders emerge during adolescence. Our
laboratory has observed that male rats show higher levels of anxiety-like behavior
compared to female rats by mid-adolescence. Cells that produce the stress peptide
corticotropin-releasing factor (CRF) within the medial prefrontal cortex (mPFC) have
been implicated in anxiety; thus, it is possible that sex differences in this peptidergic
system underlie differential expression of anxiety-like behavior in males and females.
Alternatively, sex differences in anxiety-like behaviors may be due to mechanisms
independent of prefrontal CRF. The present study used molecular and histochemical
approaches to examine the CRF system in the mPFC of adolescent male and female
rats. Sex differences were not observed in CRF immunolabeling intensity or the number
of CRF cells, CRF mRNA, or CRF type 1 receptor (CRFR1) mRNA. These data suggest
that sex differences in anxiety-like behaviors may not be due to robust sex differences in
the mPFC CRF system. I next examined if there were sex differences in cell activation in
the mPFC using the activity marker early growth responsive factor-1 (Egr-1), which is
known to have an inhibitory role in anxiety. Females had higher Egr-1 cell density in the
prelimbic cortex (PrL) and infralimbic cortex (IL) subregions of the mPFC. CRF labeling
intensity was also negatively correlated with Egr-1 cell density in these two subregions,
although this did not differ with sex. To gain insight into how CRF could negatively
modulate local cell activation in the mPFC, I conducted confocal microscopy
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experiments in a small group of animals (males and females combined). Approximately
35% of all CRF labeled terminals were closely apposed to CRFR1 puncta. The overall
co-expression of the GABAergic enzyme glutamic acid decarboxylase (GAD) and CRF in
the same terminals was relatively low in all subdivisions, but co-expression was the
highest in the infralimbic cortex subdivision (10%). This suggests that while the majority
of CRF cells in the mPFC are GABAergic, CRF cells appear to distribute GABA and CRF
to distinct terminals within the mPFC in a subregion-specific manner. These complex
interactions may fine-tune the balance of excitatory and inhibitory signaling in the mPFC
and contribute to individual variability and sex differences in stress vulnerability and
resilience.
Introduction
Vulnerability to stress-related disorders differs with sex; for example, females have
higher prevalence in major depressive disorders and posttraumatic disorders compared
to males, whereas males suffer more from substance abuse than females (Bangasser
and Valentino, 2014; Hammerslag and Gulley, 2015). In some cases, such as major
depressive disorders, the sex differences emerge as early as adolescence (Kessler et al.,
1993). Brain development trajectories differ in males and females, including the latedeveloping prefrontal cortex (Giedd and Rapoport, 2010). This brain region integrates
information from other cortical and subcortical regions, and provides additional
modulation to innate physiological and behavioral responses. Thus, the sex difference in
the prefrontal cortex of adolescents may contribute to stress reactivity and stressinduced adaptation.
In response to physiological or psychological stressors, corticotropin-releasing
factor (CRF) is released from the paraventricular nucleus of the hypothalamus to
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stimulate the hypothalamic-pituitary-adrenal axis (HPA axis, the neuroendocrine stress
pathway). In addition to its role in the classical HPA axis, CRF is also widely expressed
in cortical and subcortical regions. CRF’s function in these regions is also associated
with stress: anxiety-like behaviors, stress-induced substance use, stress-induced
arousal, etc. Sex differences in the CRF system have been shown to attribute to the
differential stress-induced arousal states between males and females (Valentino et al.,
2013b).
Based on morphological and biochemical characteristics, CRF cells have been
described as inhibitory interneurons in the cortical regions (Swanson et al., 1983; Yan et
al., 1998). These cells are sparsely distributed across all layers of the mPFC. They have
mostly bipolar shapes in layers I to III, and a subset of them have multipolar shapes in
layers V and VI of the cortex (Yan et al., 1998). CRF cells in the cortex express other
interneuron markers such as calretinin, vasoactive intestinal peptide, and somatostatin
(Kubota et al., 2011). While detailed CRF axon distribution in the mPFC remains
unknown, elegant studies using these interneuron markers indicate that axons of bipolar
cells (e.g. calretinin expressing cells) often project into deep cortical layers, whereas
axons of multipolar cells (e.g. somatostatin expressing cells) often project into superficial
cortical layers (Kawaguchi and Kubota, 1997; Cauli et al., 2014). In addition to the
morphological similarities to known interneuron populations, cortical CRF cells express
glutamate decarboxylase (GAD) that is used to synthesize gamma aminobutyric acid
(GABA) (Yan et al., 1998). These observations suggest that cortical CRF cells are
inhibitory neurons with the capability of co-releasing GABA.
Intriguingly, CRF itself has an excitatory effect. CRF has two receptors, CRFR1
and CRFR2, and CRF has higher affinity to CRFR1 than to CRFR2 (Reul and Holsboer,
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2002). CRFR1 is a G-protein coupled receptor and is the most abundant CRF receptor
type in the cortex. CRFR1 is mainly expressed in cortical pyramidal neurons (Gallopin et
al., 2006; Refojo et al., 2011). Activation of CRFR1 initiates the protein kinase A (PKA)
signaling pathway and reduces PKA-sensitive slow afterhyperpolarization current in
pyramidal neurons (Hu et al., 2011). This effect promotes the firing of action potentials
by increasing the excitability of cells. With the capability of producing both CRF and
GABA, CRF cells may have a dual effect on downstream cells in which CRF potentiates
and GABA suppresses cellular activity. It is still unclear whether CRF and GABA would
be released from the same axonal terminals or be released separately from distinct
terminals. If CRF co-exists with GABA at axonal terminals, then the opposing effects of
CRF and GABA may neutralize each other or generate a complicated activity pattern. If
CRF exists at distinct axonal terminals from GABA, then the activation of CRF cells
could produce CRF-mediated potentiating effects on postsynaptic CRFR1 expressing
cells.
Sex differences in the prefrontal CRF system could lead to differential modulation
in local cellular activity that regulate downstream functions such as neuroendocrine and
behavioral responses to stress. I conducted experiments to test this hypothesis using
adolescent animals, as our laboratory has observed sex differences in anxiety-like
behavior on the elevated plus maze at this age. Molecular and histochemical
approaches were used to examine several measures of CRF and CRFR1 in the mPFC
to test the hypothesis that there are sex differences in the prefrontal CRF system of
adolescent rats. GAD was used as a marker for GABA-containing terminals to examine
the properties of the CRF axon terminals.
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Materials and Methods
Animals
A total of 30 adolescent Wistar rats (15 males and 15 females, Charles River)
arrived on postnatal day (PD18) with dams, and were weaned on PD21. They were
housed in same-sex groups of three in plastic cages with wood chip bedding under a 12hour light/dark cycle (lights on at 8 a.m.). Animals had ad libitum access to food and
water throughout the experimental period. All procedures met the guidelines of the
Institutional Animal Care and Use Committee as well as of the National Institutes of
Health Guide for the Care and Use of Laboratory Animals. Results from one female rat
were excluded because of poor quality of brain tissue sections.
Elevated plus maze
Rats were habituated in an ambient room for at least 10 minutes before they were
tested in an elevated plus maze at the beginning of the dark phase of the light/dark cycle.
At the beginning of the test, each rat was put at the central square with its head facing
one of the close arms. Experimenters then left the room and let the rat freely explore the
maze for 5 minutes. The whole process was recorded using an overhead surveillance
camera for further analysis. At the end of a 5-minute session, the rat was returned to the
home cage, and the maze was cleaned using water. The % time spent in the open arm
and % entries to the open arm were parameters for anxiety-like behaviors, in which
lower percentage in these two measurements indicated higher anxiety levels. The
number of close arm entries was used as an indicator of locomotor activity.
Brain tissue collection
Adolescent rats were intracardially perfused with cold 4% paraformaldehyde in
0.1M borate buffer, pH 9.5. The perfusions were started after the lights came on at 8 a.m.
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and were finished by noon (the order of perfusion was counterbalanced across groups).
Although DEPC-treated water was not used during perfusion procedures, formaldehyde
itself has been shown to inhibit ribonucIease (RNase) activity by cross-linking proteins
(e.g. Jonsson and Lagerstedt, 1959). The cold and basic fixative created an unfavorable
environment for RNase activity (e.g. RNase A has the highest activity at pH 7.6 and
60ºC) and it has been used for measuring RNA using in situ hybridization (Richardson et
al., 2008a). In the present study, I tested the integrity of the RNA from my samples using
a Bioanalyzer (Agilent Technologies, Inc.), and found it had sufficient quality for
quantification analysis (see below and Appendix I for details). Brains were post-fixed for
4 hours at 4ºC and submerged in 20% sucrose in 0.1M phosphate buffer, pH 7.4 for 48
to 72 hours before snap-frozen in isopentane (2-methylbutane, Fisher Scientific) as
previously described (Richardson et al., 2006). Brains were stored at -80ºC until sliced
into 35 µm coronal sections on a freezing microtome. Sliced sections were then stored in
cryoprotectant (30% ethylene glycol, 30% sucrose, and 1% polyvinylpyrrolidone in 0.1M
phosphate-buffered saline) at -20ºC before immunolabeling.
Immunohistochemistry
Brain sections of interest were rinsed in five 5-minute 0.1M phosphate buffer saline
washes (PBS, pH7.4) to remove the cryoprotectant. Further rinses with Triton X-100
containing PBS (PBST; 0.3% Triton X-100 in PBS, pH7.4) were used to make the cell
membrane finely porous. A 30-minute 3% hydrogen peroxide (H2O2 in PBS) incubation
to eliminate endogenous peroxidase activity was followed by a blocking step of a onehour incubation with 5% non-fat milk. Rabbit anti h/r CRF antiserum (1:20,000, gift from
Dr. Paul Sawchenko at the Salk Institute, La Jolla, CA) or rabbit anti Egr-1 (1:5000,
Santa Cruz) was prepared in 5% non-fat milk and 10% normal goat serum in PBST. The
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primary antisera were incubated for 16 to 18 hours at 4ºC. After further PBST rinses,
brain sections were incubated with biotinylated goat anti rabbit IgG antiserum (1:200,
Vector Laboratories) in PBS for two hours at room temperature. Streptavidin-conjugated
horseradish peroxidase (HRP) was applied for 1 hour at room temperature. The
chemical substrate for peroxidase, 3,3’-diaminobenzidine (DAB, Vector Laboratories)
with nickel was used for the final color reaction. After immunolabeling, the sections were
mounted on gelatin-coated glass slides, dehydrated, and cleared before coverslipping.
The dehydration and clearing process included 2 minutes in 70% ethanol, 2 minutes in
95% ethanol, two 2-minute rinses in 100% ethanol and three 5-minute rinses in xylene.
Slides were then coverslipped with DPX mounting media (Sigma-Aldrich) for microscopic
analysis.
CRF intensity measurement
Photomicrographs of CRF immunolabeling in the subregions of the mPFC were
taken under a 20X objective using a Leica microscope attached to a DP71 Olympus
camera. Individual photomicrographs covered areas from cortical layer II to VI. All
images were taken under the same microscopic settings. The light intensity was finely
adjusted for each cohort of animals to produce comparable background signal in all
samples. Photomicrographs were analyzed using the ImageJ software package
(Rasband, 1997). Colored images were converted into 8-bit, inverted, and calibrated with
proper scale unit. Background signal was generated using a Gaussian filter with a
diameter of 7.5 µm for each image, and was subtracted. The mean of all background
subtracted images plus three standard deviations was used as the threshold for %
covered area measurement. This intensity measurement consisted of both CRF soma
and fibers.
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CRF cell counts
Slides containing mPFC sections were digitally scanned at high resolution using a
20X objective under bright field illumination by Aperio ePathology (Leica Biosystems).
Two sections (350 µm apart from each other) containing CRF immunoreactive (CRF-ir)
cells were used as a representative of the CRF population in the mPFC. Given this
distance in sampling my interval and the fact that CRF cells are less than 10 µm in
diameter and rarely overlap with one another in the mPFC, it is unlikely that I would
double count cells in my studies. Nevertheless, to avoid biased sampling, I counted all
CRF cells in each subregion of the mPFC rather than using several small sampled
regions of interest. Subregions including the anterior cingulate cortex (AC), prelimbic
cortex (PrL), and infralimbic cortex (IL) were defined using the corpus callosum as an
anatomical marker (Figure 16B). Areas of interest were traced and measured in
ImageScope software (Leica Biosystems). Experimenters blind to the treatment groups
counted CRF-ir cells under 10X magnification of the slide images. The criteria for
identifying CRF-ir cells were a clearly defined border of the soma and some extended
neurites.
Reverse transcription and real time quantitative polymerase chain reaction (RTqPCR)
Brain slices containing the mPFC (4 slices per animal, across Bregma 3.72 – 2.52
mm) were sorted out and rinsed in five 5-minute washes with 0.1M PBS, pH 7.4 made
with DEPC-treated water. The mPFC was isolated under a dissection microscope
(Figure 16C). The total RNA from collected tissue sections was extracted using Qiagen
miRNeasy FFPE kits (Qiagen). RNA extracted from perfused brain tissues are known to
be fragile and heavily modified by formaldehyde. To optimize the quality of RNA,
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protease K digestion and high temperatures were used to reverse crosslinks between
RNA and proteins. The integrity of RNA samples was analyzed using a Bioanalyzer
(Agilent Technologies, Inc.; Figure 22 in Appendix). The quantity and quality of RNA
were estimated using a NanoDrop 1000 spectrophotometer (ThermoFisher). Equal
amounts of RNA from each animal were used in the reaction of reverse transcription
using SuperScriptTM III First-Strand Synthesis SuperMix for qRT-PCR (Invitrogen). This
SuperMix contained random hexamers for reverse transcription, which increases the
cDNA synthesis efficiency from fragmented RNAs when compared to oligo-dT primers
alone. In order to acquire similar Ct values (around 25) between target and house
keeping genes (18S rRNA and cyclophilin A) in qPCR reactions, different amounts of
cDNA were used for different genes (QuantiFast SYBR® Green PCR Kit, Qiagen). The
amount of cDNA used for CRF, CRFR1, cyclophilin A and 18S rRNA was 2.5, 2.5, 10-2,
and 10-5 µL, respectively. Quantitative PCR reactions (20 µL) were carried out in a 96well plate RealPlex machine (Eppendorf). The primer sequences are listed in Table 7.
The PCR products of CRF, CRFR1, 18S rRNA, and cyclophilin A were 96 bps, 248 bps,
151 bps, and 127 bps. The relative transcript level of the target genes (CRF or CRFR1)
to the control genes (18S rRNA) was analyzed using a 2-∆∆Ct method (Livak and
Schmittgen, 2001) (∆∆Ct = (CtCRF or CRFR1 – Ct18S rRNA) – (CtCRF or CRFR1 of females – Ct18S rRNA of
males))

and results were presented as percent of adolescent male group. The results from

comparing CRF and CRFR1 to both house keeping genes were similar, thus only results
using 18S rRNA were shown.
Egr-1 cell counts
Egr-1 was used as an activity marker because this immediate early gene responds
to activation of glutamate receptors and has high expression at basal levels (Beckmann
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and Wilce, 1997; Herdegen and Leah, 1998; Knapska and Kaczmarek, 2004).
Photomicrographs were obtained with consistent parameters across all animals using a
20X objective on a Leica microscope attached to a DP71 Olympus camera. ImageJ
software was used for the following analysis procedure (Rasband, 1997). All digital
images were converted to 8-bit, inverted, and calibrated (2.58 pixels per µm). In each
image, a few Egr-1 labeled cells with medium-labeled intensity were selected and used
to set the threshold using the Maximum Entropy algorithm. This selection method
defined cells with medium-to-high labeling intensity and excluded cells that were
indistinguishable from background. The Analyze Particles function was used to quantify
the number of Egr-1 positive cells. The parameters for defining a cell were 200-1000
pixels for size (30-150 µm2) and 0.6-1.0 for circularity. The defined cells were confirmed
by overlay outlines on the original images. The watershed function was not applied so as
to avoid false-positive cell counts. An average number across hemispheres and sections
was used to represent the number of Egr-1 positive cells in each animal.
CRF/CRFR1 double immunofluorescent labeling
Prefrontal sections were sorted out from cryoprotectant. For CRFR1 and CRF
double labeling, sections were rinsed in PBS for three 5-minute washes, and then rinsed
in 0.1M Tris buffered saline (TBS, pH 7.5) for another three 5-minute washes.
Autofluorescence was blocked by incubating sections with 50 mM ammonium chloride
prepared in the TBS with 0.25% Triton-X 100 (TBST) for 20 minutes at room
temperature. Two percent bovine serum albumin (BSA) in TBST was used for a 30-min
blocking procedure. Sections were incubated with goat anti CRFR1 (Santa Cruz, sc1757, 1:500 in TBST with 0.05% BSA and 3% normal donkey serum) antibody solution
for 48 hours at 4ºC. Three 10-minute washes with TBST were carried before a 90-minute
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secondary antibody incubation (Invitrogen, donkey anti goat IgG conjugated Alexa 488,
1:200 in TBST with 2% BSA and 5% normal donkey serum). After one rinse with TBS
and two rinses with PBS, sections were incubated with 3% normal goat serum (NGS) in
PBS with 0.3% Triton-X 100 (PBST) for 30 minutes. After a few more washes with PBS,
sections were incubated with rabbit anti h/r CRF (1:5000 in PBST with 3% NGS, gift from
Dr. Paul Sawchenko at the Salk Institute, La Jolla, CA) antibody solution for 24 hours at
4ºC. Goat anti rabbit IgG conjugated with biotin (Vector, 1:200 in PBST with 2% BSA and
5% NGS) was used as the secondary antibody for CRF labeling. The secondary
antibody incubation was carried out for 90 minutes at room temperature. Cy3-striptavidin
conjugates (Invitrogen, 1:1000) were prepared in PBST and applied for an hour at room
temperature. Tissue sections were mounted on gelatin-coated slides, dried, cleaned with
three xylene rinses (20 seconds, 1 minute, and 1 minute), and coverslipped with DPX
mountant (Sigma-Aldrich).
CRF/CRFR1 confocal imaging and colocalization analysis
A Nikon A1 system was used for confocal imaging (Single Molecule/ Live Cell
Imaging Facility, University of Massachusetts Amherst). Images were taken from layer
II/III and layer V/VI of the mPFC subregions under a 60X objective (N.A. = 1.4) with
Nyquist zoom (3.5X). Z-stacks across 5 µm were taken at 250 nm z steps. Each z-stack
contained 20 image slices. Two one-µm thick slices (slices 6-10 and slices 11-15) from
CRF and CRFR1 labeling were generated using the maximum projection method and
used for analysis. The CRF and CRFR1 projected images were set threshold using
MaxEntropy and Default algorithms using the Auto Threshold function in ImageJ,
respectively. Each subregion was analyzed using 24 to 32 images. All images were
converted into binary formats and were despeckled once. The despeckle function
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removed salt-and-pepper noise. CRF puncta were defined as particles that had sizes
between 0.06 and 1 µm2. These puncta were identified using the Analyze Particles
function and added into ROI (region of interest) manager. These ROIs were overlaid with
the CRFR1 image from the same location, and the amount of CRFR1 signals was
measured from the ROIs. When the CRFR1 signals in CRF ROIs were larger than zero,
these ROIs were defined as close appositions between CRF and CRFR1.
CRF/GAD double immunofluorescent labeling
For GAD65/67 and CRF double labeling, brain tissue sections were processed
with 50 mM ammonium chloride in PBST for 20 minutes to reduce autofluorescence.
PBST with 2% BSA and 3% NGS was applied for 30 minutes for blocking. Tissue
sections were incubated with rabbit anti h/rCRF antibody solution (a gift from Dr. Paul
Sawchenko, Salk Institute, La Jolla CA, 1:5000 in PBST with 3% NGS) for 24 hours at
4ºC. Biotinylated goat anti rabbit IgG antisera (Vector, 1:200 in PBST with 2% BSA and
5% NGS) was used to recognize CRF antibody and the incubation was carried out for 90
minutes at room temperature. Cy3-striptavidin conjugates (Invitrogen, 1:1000) were
prepared in PBST and applied for 1 hour at room temperature. Additional PBS rinses
were followed by incubation in rabbit anti GAD65/67 antiserum (Millipore AB1511, 1:200)
in PBST with 3% NGS for 72 hours at 4ºC. After three 10-minute washes with PBS,
tissue sections were incubated with Cy2-conjugated goat anti rabbit antiserum (Vector,
1:500 in PBST with 2% BSA and 5% NGS) for 90 minutes at room temperature. A
control group with CRF labeling followed by Cy-2 conjugated goat anti-rabbit antiserum
incubation showed low or no interaction between this secondary antiserum and CRF
antiserum (data not shown). DAPI was used as a nucleus marker. Tissue sections were
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mounted on gelatin-coated slides, dried, cleaned with three xylene rinses (20 seconds, 1
minute, and 1 minute), and coverslipped with DPX mountant (Sigma-Aldrich).
CRF/GAD confocal imaging and colocalization analysis
A Nikon A1 system was used for confocal imaging (Single Molecule/ Live Cell
Imaging Facility, University of Massachusetts Amherst). Images were taken at layer II/III
and layer V/VI of the mPFC subregions under 60X objective (N.A. = 1.4) with Nyquist
zoom (3.5X). Results from each subregion were analyzed using six to eight confocal
image stacks. All image analyses were conducted using ImageJ (Rasband, 1997).
CRF and GAD double-labeled Images were deconvoluted with five iterations using
a Deconvolution plugin (Dougherty, http://imagej.net/Deconvolution). Deconvolution
increased the visibility of GAD-labeled structures (Figure 19). After deconvolution, CRF
and GAD colocalization was analyzed using the JACoP plugin (Bolte and Cordelières,
2006). Object-based colocalization was focused on particles between 0.06 to 2 µm2 (4140 pixels).
Statistical analysis
A student t-test was used to analyze sex differences in the results of elevated plus
maze and in the CRF and CRFR1 mRNA levels. Subregional differences in CRF labeling
intensity, CRF cell density, and Egr-1 cell density were analyzed using a mixed-model
ANOVA with sex as a between-subject variable and subregions as a within-subject
variable. Subregional differences in CRF/CRFR1 close appositions and CRF/GAD
colocalized puncta were analyzed using a paired Wilcoxon signed rank test (data were
combined for males and females). A post hoc power analysis was conducted by using
the value from the double labeling studies of CRF/CRFR1 and CRF/GAD. Differences
were considered significant at p ≤ 0.05. Data were expressed by means plus standard
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error with individual data points. All statistical analyses were performed using R
statistical software package in RStudio (R Core Team, 2014).
Results
Adolescent males expressed more anxiety-like behaviors than females (Karanikas
et al., unpublished observation)
Adolescent naïve male and female rats were tested on the elevated plus maze
(EPM). Each group contained 6 animals. Males spent 50% less time in the open arm
than females did (Figure 15, p < 0.05). Both groups showed similar locomotor activity
(Figure 15)—quantified by close arm entries, indicating reduced exploration in the open
arms likely reflects higher anxiety-like behavior in adolescent males.
No sex differences at the expression level in the CRF system of the mPFC in
adolescents
Adolescent male and female rats were used to examine sex differences in the CRF
system of the mPFC. CRF cells and fibers were visualized using immunohistochemistry.
In order to capture different aspects of the CRF population, I analyzed CRF labeling
intensity (soma plus fibers) and CRF cell density (soma only) from the same animals.
CRF labeling intensity was measured from sampled mPFC subregions (Figure 16A, left).
No sex or subregional differences were observed in the CRF labeling intensity in the
mPFC subregions (Figure 16A, right, all p > 0.05). Next, mPFC subregions were traced
and every CRF cell within each subregion was manually counted (Figure 16B, left). No
sex differences were observed in overall CRF cell density in the mPFC (Figure 16B, right,
p > 0.05), but CRF density differed across subregions (Figure 16B, right, F(2,30) = 11.08,
p < 0.001). A pairwise-t test with Bonferroni p-value correction revealed that CRF cell
density in the PrL and IL was higher than the AC (PrL, p = 0.08; IL, p < 0.01). Positive
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correlations between CRF labeling intensity and CRF cell density were observed in the
PrL, but not in the AC and IL (AC, R2 = 0.05, p > 0.05; PrL, R2 = 0.27, p = 0.03; IL, R2 =
0.04, p > 0.05). These correlations suggest that the labeling intensity in the PrL was
contributed mainly by soma labeling.
To analyze CRF and CRFR1 mRNA from the same animals that had been used in
the CRF immunolabeling analyses, total RNA from the mPFC of perfused brain slices
were used (Figure 16C, left). Similarly, no sex differences were observed in the CRF and
CRFR1 mRNA (Figure 16C, right, all p > 0.05). No significant correlation was found
between CRF mRNA level and CRF labeling intensity or CRF cell density (data not
shown), which suggests potential posttranscriptional modifications of CRF synthesis in
mPFC CRF cells.
Close apposition between CRF and CRFR1 in the subregions of the mPFC
To examine CRF and CRFR1 synaptic connections, prefrontal brain slices from six
adolescent rats were analyzed using confocal imaging and close apposition analysis.
Potential synaptic connections were defined within 1 µm3 voxel. Slices from a z-stack
across 1 µm were projected into an image, and puncta size between 0.06 and 1 µm2
were analyzed (see Materials and Methods and Figure 17A). I found that approximately
35% of CRF puncta were closely apposed to CRFR1 in the mPFC, and this percentage
was comparable across the three subregions (Figure 17B, N=6 from an equal number of
males and females, paired Wilcoxon signed rank test, all ps > 0.05). There were not
enough animals to compare males to females in the present study. A post-hoc power
analysis predicted that an n of > 25 animals per group would be required to detect a sex
difference given the observed effect size.
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Cell activation in the mPFC was higher in females and CRF labeling intensity
negatively correlated with activity in both sexes.
When cell activation was examined in the mPFC using Egr-1 as an index, females
had a higher Egr-1 cell density than males in the PrL and IL but not in the AC (Figure
18A; AC, p > 0.05; PrL, p < 0.01; IL, p < 0.01). Negative correlations between CRF
immunoreactivity and Egr-1 cell density were observed in the PrL and IL (Figure 18B,
PrL, R2 = 0.40, p < 0.05; IL, R2 = 0.25, p = 0.10).
Colocalization of CRF and GAD terminals in the subregions of the mPFC
Colocalization of CRF and GAD immunolabeled puncta in the mPFC was
investigated in six adolescent animals. Surprisingly, CRF and GAD were rarely observed
in the same puncta (Figure 19A). The overall colocalization ratio in puncta was 5-20% in
the three mPFC subregions. CRF and GAD puncta were also found to be adjacent to
each other on occasion (Figure 19A). Subregional differences were found, with the
lowest colocalization in the AC compared to the PrL (Figure 19B, N=6 from an equal
number of male and female rats, paired Wilcoxon signed rank test, AC vs. PrL, V=0,
p=0.03; AC vs. IL, V=1, p=0.06). There were not enough animals to compare males to
females. A post-hoc power analysis predicted that an n of > 44 animals per group would
be required in future studies to detect a sex difference given the observed effect size.
Discussion
Sex differences in stress-related disorders occur as early as adolescence.
Previously our laboratory found that males had higher anxiety-like behaviors than
females on PD43 when rats were tested using an elevated plus maze. Because the CRF
system in the mPFC mediates anxiety-like behaviors, it was hypothesized that males
would have an upregulated CRF system in the mPFC compared to females by mid94

adolescence. Sex differences can happen at two levels: baseline and stress-induced
reactivity. In this chapter, I examined the indices of CRF and CRFR1 under baseline
conditions and found no measurable differences between males and females in CRF
labeling intensity, CRF cell density, and CRF and CRFR1 mRNA in the mPFC. Cell
activation using Egr-1 as an index in the mPFC was higher in females and CRF
immunolabeling inversely related to cell activation in both sexes, suggesting that
mechanisms downstream of CRF are more likely involved, or that exposure to a stress
may be necessary to reveal a sex differences in the CRF system in the mPFC.
In my confocal studies, three males and three females were used to investigate the
CRF/CRFR1 close apposition and CRF/GAD colocalization. The small sample size was
not sufficient to study sex differences, especially when puberty status and hormonal
fluctuations in adolescent animals are considered.
CRF cells express GAD and thus are assumed to be GABAergic interneurons. It is
possible that CRF and GABA may have opposing effects that lead to distinct synaptic
functions when CRF and GABA are released from the same versus different terminals.
Alternatively, if these two neurotransmitters are released from different terminals as my
data suggest, then the neuromodulatory effect of CRF cells on pyramidal circuitry may
be complex. For example, a single CRF cell may have one GABA terminal that synapses
on an interneuron to disinhibit a CRFR1 pyramidal cell while a second terminal synapses
directly onto a CRFR1 pyramidal cell and excites it directly by releasing CRF. The end
result would be an overall increase in excitability. If the proportion of independent
release versus co-release of GABA and CRF changes with life experiences such as
exposure to stress or alcohol, this neuroadaptation could potentially lead to robust
changes in the excitability of the mPFC and downstream functions.
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Bangasser et al. (2010) showed that females have higher CRFR1 and G protein
coupling in the cortex compared to males under basal (unstressed) conditions. Stress
alters the coupling in males and abolishes the sex difference (Bangasser et al., 2010).
My observation of no sex differences in CRF mRNA at basal levels was consistent with
results from Uban et al. (2013), whereby adult males and females have similar basal
levels of CRF mRNA in the PrL and IL. However, CRF expression level in the female
mPFC are more sensitive to the additive effects of prenatal alcohol exposure and adult
chronic stress than males (Uban et al., 2013). In the locus coeruleus, females have
fewer CRFR1s that associate with endocytosis machinery compared to males. Lower
levels of internalization of CRFR1 results in higher levels of CRFR1 activation in females
(Bangasser et al., 2010; Valentino et al., 2013a). It is therefore possible that the sex
difference in adolescents may occur through differential CRF/CRFR1 signaling, or sex
differences may only be detectable under specific conditions such as after a stress
challenge in the mPFC CRF system.
In the current study, I used perfused brain slices to directly compare the protein
and mRNA levels in the same anatomical location in the same animals. Two potential
caveats could undermine the validity of gene analysis using formaldehyde-fixed tissue.
One is RNA fragmentation and degradation that could occur during the perfusion
procedure. The other is chemical adducts from formaldehyde, which could impede cDNA
synthesis and lead to partial amplification of transcripts. The RNA integrity of my
samples was discussed in the Appendix I. In short, RNA may begin to degrade in the 5min saline perfusion window before formaldehyde inactivates RNase activity (Jonsson
and Lagerstedt, 1959). The basic pH (pH 9.4) and low temperature (4ºC) of the fixative
can also reduce RNase activity. Long fixation times, presumably over 24 hours, could
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result in increased irreversible chemical modification of RNA, and cause degradation
(Ahlfen et al., 2007). RNA degradation can also occur during a high-temperature
paraffin-embedding procedure. However, I used a 4-hour post-fixation without paraffin
embedding. My RNA samples showed some evidence of degradation, but overall the
fixation procedure appears to have minimized aversive effects on RNA integrity and
preserved large RNA fragments (Appendix I).
Formaldehyde chemically modifies RNA molecules and these chemical adducts
can interfere with reverse transcription reactions. Demodification is essential for
optimization for gene expression analyses (Evers et al., 2011). Evers et al. (2011)
suggests an optimized condition for demodification in which a short high-temperature
incubation with buffer that has the likely composition of protease K buffer provided the
best result. During RNA extraction, I removed the formaldehyde modification using a 15min incubation at 80ºC in protease K buffer. Although the efficiency of removing
chemical adducts was not further examined, I assume all samples had similar
demodification across all RNA species because samples were treated similarly. To
transcribe fragmented RNA samples at the maximum efficiency, I used both poly-dT
primer and random hexamers in reverse transcription reactions. Short amplicons (below
250 bps) were used in the qPCR reactions to avoid partial or unsuccessful amplification
of long amplicons from fragmented templates (Ahlfen et al., 2007). Although several
approaches have been used to optimize this assay, I cannot rule out all unknown factors
that could potentially contribute to variability in mRNA levels, e.g., there may be
differential rates of chemical modification by formaldehyde or differential mRNA
degradation in various RNA species. Further comparisons between perfused and fresh-
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frozen tissue would provide more information about baseline expression of CRF and
CRFR1 mRNA in males and females.
A previous report shows that reducing Egr-1 protein levels in male rats in the
mPFC reduces social interaction, an indication of increased anxiety (Stack et al., 2010).
My observation on the relationship between Egr-1 level in the mPFC and anxiety-like
behaviors between males and females are in agreement with the report from Stack et al.
(2010). In contrast to the present finding in adolescent animals, Stack et al. (2010)
showed that adult male rats have higher Egr-1 mRNA levels under both basal conditions
and after social interaction tests compared to adult females (Stack et al., 2010). This
suggests that Egr-1 may increase during development in males. It should also be noted
that the two studies also differed in the time of the day when brain samples were
collected (light phase of the light/dark cycle in the current study, but it was not stated in
Stack et al. (2010) study), detection methods that were used (immunohistochemistry
versus in situ hybridization and western blot), and rat strains (Wistar vs. SpragueDawley). It has been shown that Egr-1 expression level varies between the light and
dark phases of the light/dark cycles under basal conditions (Rönnbäck et al., 2005). It is
possible that males and females have differential Egr-1 expression in the mPFC at
different times of a day, which may also modify the behavioral output.
Activation of CRFR1 by CRF or specific agonists in the cortex has a variety of
effects. CRF can have an excitatory effect. When a cortical cell is depolarized to a subthreshold level, CRF application initiates and prolongs action potentials (Gallopin et al.,
2006). When CRF binds to CRFR1 in the cortex, it initiates the protein kinase A signaling
pathway and reduces afterhyperpolarization currents (Hu et al., 2011). This effect makes
CRFR1 expressing cells more excitable. Liu et al. (2015) reported that CRF increases
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frequencies of excitatory postsynaptic currents in the mPFC, and this effect is mediated
by CRFR1 (Liu et al., 2015). In contrast, CRF has been shown to decrease cellular
activity by synergistically potentiating the effect of dopamine and serotonin in the
prefrontal cortex. Application of CRF alone does not influence the cortical cellular activity
of the cells. However, when CRF is presented with dopamine or serotonin, CRF further
reduces the overall cellular activity through decreasing excitatory postsynaptic current or
prolonging inhibitory postsynaptic current, respectively (Tan et al., 2004; Orozco-Cabal
et al., 2008). In this chapter, I found that CRF labeling intensity negatively correlated with
the cell activation marker, Egr-1, in the PrL and IL of adolescent rats. This result
suggests that CRF cells provide an inhibitory control of the local cellular activity in the
PrL and IL. This idea was supported by the higher percentage of CRF/GAD dual-labeled
puncta in the PrL and IL than in the AC. These findings provide anatomical evidence of
differential CRF function in the subregions of the mPFC, although it is still unclear
whether CRF and GABA are co-released from the same axonal terminals, and if they are
co-released, how CRF simultaneously functions with GABA at synapses.
GAD is the rate-limiting enzyme for GABA synthesis, and expression of GAD has
been used as a marker for GABAergic cells. Using single-cell PCR, Gallopin et al. (2006)
reported that 89% of CRF expressing cells in the somatosensory cortex also express
GAD. Colocalization of CRF and GAD in the cortex suggests that cortical CRF cells are
capable of producing GABA and providing inhibitory control over postsynaptic neurons.
In this chapter, I hypothesized that CRF cells produce both CRF and GABA and both
molecules co-exists at the same terminals. Alternatively, CRF cells may distribute CRF
and GABA at different axonal terminals. Object-based colocalization analysis showed
that less than 20% of CRF terminals contained GAD. This result excluded the all-or-none

99

hypotheses of the CRF/GAD relationship at axonal terminals in the mPFC. It is likely that
co-release of CRF and GABA is not the most common mechanism in the mPFC (Figure
20). Instead, CRF and GABA could be produced from the same cell, but transported to
separate terminals at different cortical layers for different functions.
Because only a proportion of CRF puncta were colocalized with GAD, those GADnegative CRF terminals may contain just CRF or may be glutamatergic terminals.
Around 10% of the CRF cell population in the somatosensory cortex expresses vesicular
glutamate transporter 1 (Gallopin et al., 2006), which indicates that some CRF cells
could package glutamate at axonal terminals. In addition, cortical GABAergic cells also
express vesicular glutamate transporters, suggesting an ability to package glutamate in
these cells (Mestikawy et al., 2011). This evidence expands the functional possibilities of
CRF terminals in which CRF may be released by itself or with either GABA or glutamate.
Similar observations have been made in the locus coeruleus. Norepinephrine neurons in
the locus coeruleus receive abundant CRF input from the central nucleus of the
amygdala (CeA) (Van Bockstaele et al., 1998). These CRF terminals are either
glutamatergic or GABAergic in the peri locus coeruleus (Valentino et al., 2001).
Interestingly,

these

CeA-originated

CRF

terminals

form

mostly

glutamatergic,

asymmetric connections to the downstream targets even though those CeA CRF cells
are GABAergic (Veinante et al., 1997; Van Bockstaele et al., 1998). Future studies on
detailed CRF terminal compositions using electrophysiology and electron microscopy
would clarify properties of CRF-containing synapses in the mPFC.
Conclusion
Altogether the data of this chapter suggest that the CRF/CRFR1 system does not
differ in adolescent males and females in the mPFC under basal conditions. Instead, sex
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differences appear to occur downstream of CRF, evidenced by lower Erg-1 in males
compared to females. Although the majority of CRF cells in the mPFC are GABAergic,
the confocal analyses herein suggest that CRF cells appear to distribute GABA and CRF
to distinct terminals of the mPFC in a subregion-specific manner. Perhaps the
composition of CRF, GABA, and CRF/GABA terminals could fine-tune the balance of
excitatory and inhibitory signaling in the mPFC, and contribute to stress vulnerability and
resilience.
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Figure 15. Adolescent males show higher anxiety-like behaviors than females
using elevated-plus maze.
Adolescent males had lower % open arm time then females when rats were tested using
elevated-plus maze (*, p<0.05). No differences in the close arm entries indicated that the
difference in % open arm time was not due to a change in locomotor activity. n = 6 per
sex.
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Figure 16. Adolescent males and females had similar levels of CRF labeling
intensity, CRF cell number, CRF mRNA, and CRFR1 mRNA in the mPFC.
(Left) Red lines illustrate sampling areas in the mPFC. (Right) Bar graphs for quantitative
results. A. CRF labeling intensity measured both CRF soma and fibers. B. CRF cell
density measured all CRF cells within the sampled regions. C. CRF and CRFR1 mRNA
level was measured from the mPFC of perfused brain sections. n = 8-9 per sex.
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Figure 17. CRF/CRFR1 close appositions in subregions of the mPFC in adolescent
rats.
Close apposition of CRF and CRFR1

A. Photomicrographs of CRF and CRFR1
double labeling in the mPFC. Upper panel
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showed original confocal images resulted
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MaxProjection across 1 µm thickness.
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Lower panel showed images that were thresholded for final analysis. Arrows pointed to
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CRF and CRFR1 close appositions, which were potential CRF/CRFR1
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analysis (N = 6).
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Figure 18. CRF labeling intensity negatively correlated with local cell activity in
the PrL.
A. (Left) Illustration of sampled brain sections and subregions in the mPFC. (Right)
Adolescent females had higher Egr-1 cell density in the PrL and IL than males. B. CRF
labeling intensity negatively correlated with Egr-1 cell density in the PrL and IL but not in
the AC. n = 6 per sex.
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Figure 20. Hypothesized CRF synaptic connection models in the medial prefrontal
cortex.
CRF cells in the mPFC express glutamic acid decarboxylase (GAD), suggesting that
these cells are capable of producing GABA and could potentially release CRF and
GABA from the same terminals. In a pilot study using an object-based colocalization
analysis, I found that only a small proportion of CRF and GAD colocalization in puncta
(8-10%). This result suggests that in the mPFC most CRF terminals may not contain
GABA.
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Table 10. Primer sequences used in the RT-qPCR experiments.
Gene name
CRF
(NM_031019.1)
CRFR1
(NM_030999.4)
18S RNA
(M11188)
Cyclophilin A
(NM_017101.1)

Forward primer

Reverse primer

ACCTGCCAAGGGAGGAGA

GCAGACAGGGCGACAGAG

TCCACTACATCTGAGACCATT
CAGTACA

TCCTGCCACCGGCGCCACCT
CTTCCGGA

GTAACCCGTTGAACCCCATT

CCATCCAATCGGTAGTAGCG

TATCTGCACTGCCAAGACTGA
GTG

CTTCTTGCTGGTCTTGCCATT
CC
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CHAPTER 5
GENERAL DISCUSSION
Potential roles of prefrontal CRF as a risk factor to alcohol use disorder
Dysfunctional CRF in the brain has been reported in the development and
maintenance of alcohol use disorder (Zorrilla et al., 2014). Systemic blockade of CRFR1
reduces augmented drinking induced by alcohol withdrawal and stress (reviewed in
Phillips et al., 2015). The effect of CRFR1 antagonist indicates a positive relationship
between alcohol drinking and brain CRF systems; however, this relationship has yet to
be widely examined in the prefrontal cortex. To investigate whether high expression of
CRF peptide in the mPFC predisposes animals to heavy alcohol drinking or whether
alcohol drinking upregulates CRF in the mPFC, a first step was taken to examine the
these peptidergic cells in the subregions of the mPFC using two different animal models.
A predator-odor stress model was used to screen animals as stress-vulnerable or stressresilient. It has been shown that stress-vulnerable animals have higher avoidance to
odor-paired context and drink more alcohol than stress-resilient animals (Edwards et al.,
2013). I found that stress-vulnerable animals had higher CRF cell density in the vmPFC
than stress-resilient and control animals (Figure 7B). In addition, CRF cell density in the
vmPFC positively correlated with avoidance levels (Figure 7B). Because stressvulnerable animals are known to drink more alcohol than stress-resilient and control
animals, my data suggest that increased CRF cell density in the vmPFC may predispose
alcohol drinking. The potential predisposition role of CRF in the vmPFC to alcohol
drinking echoes previous findings that alcohol-preferring mice (C57BL/6J) have higher
levels of frontal cortical CRF peptide than alcohol non-preferring mice (C3H/CRGL/2)
(George et al., 1990). However, an opposite observation has been described in alcohol
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preferring and non-preferring rats (P and NP rats) where P rats have lower prefrontal
CRF peptide levels than NP rats (Ehlers et al., 1992). In the same report, Ehlers et al.
(1992) also showed that P rats are more responsive to intracerebroventricular injection
of CRF than NP rats using electroencephalographic (EEG) measurements. Together
with lower CRF peptide level and higher CRF responsive EEG power, it is possible that
upregulated CRF receptors in the frontal cortex contribute to increased alcohol
preference and/or intake in P rats. Altogether these results suggest that escalated
alcohol drinking is contributed by an upregulated CRF system in the vmPFC, which
could be shown in increased CRF expression level or CRF receptor reactivity.
George et al. (2012) reported that chronic, intermittent alcohol exposure
(intermittent group) increases CRF cell number in the mPFC when compared to chronic
continuous alcohol exposure (continuous group) in adult male rats. Because the
intermittent group shows more escalation in alcohol intake compared to the continuous
group, this result leads to the hypothesis that chronic, intermittent alcohol exposure
upregulates the CRF system in the mPFC, and this adaptation promotes later alcohol
drinking. In the adolescent binge-drinking model, binge-drinking rats had lower CRF
labeling intensity in the PrL and IL than control rats at the end of a two-week bingedrinking period in both adolescent males and females (Figure 12). Moreover, alcohol
exposure without binge drinking may not be sufficient to induce a decrease in CRF
labeling intensity of the PrL and IL (Figure 14). These results indicate that binge-drinking
patterns may have additive influences on alcohol drinking, and does not support my
hypothesis that chronic alcohol exposure upregulates the CRF system in the mPFC. In
George et al. (2012), the authors made comparisons between two different drinking
patterns (intermittent versus continuous) without having a control group that was alcohol-
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free. In addition, they examined the CRF population in the mPFC 24 hours after the last
drinking period, whereas our animals were examined 4 to 7 hours after the last drinking
bout. It is possible that chronic alcohol exposure leads to a decrease in the CRF of the
mPFC, and CRF production may begin to increase during the abstinence period. Future
examination at different time points would clarify how fluctuation of CRF levels in the
mPFC contributes to alcohol drinking. In summary, these results suggest a reciprocal
relationship between the CRF population of the vmPFC and alcohol drinking, in which
this population predisposes alcohol drinking, and alcohol consumption decreases CRF
peptide levels. If these peptide levels continue to remain low into abstinence this
neuroadaptive change may be protective and prevent heavy drinking in the future.
However, if this neuroadaptive change is temporary and peptide levels rebound
significantly, elevating above normal levels during the first few days/weeks of abstinence
they may end up increasing risk by potentiating relapse. Future studies extending the
timeline of alcohol-induced changes in vmPFC CRF and pharmacological manipulation
of CRF signaling could address these hypotheses.
Next, to examine how CRF involves in the mPFC microcircuitry, cell activation
markers (pERK and Egr-1) were used to test the relationship between activation of CRF
populations and avoidance behavior, and between CRF and local cell activation.
Although stress or alcohol treatments had less impact on CRF measurements in the
dmPFC than in the vmPFC, I found that CRF in these subregions may differentially
modulate local cell activation, and that this effect was treatment-dependent. In the
dmPFC of predator-odor stressed animals, resilient and vulnerable animals had opposite
relationships between percent activated CRF cells and avoidance levels, whereas in the
vmPFC, this relationship was likely to be unidirectional (Figure 9). These results suggest
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that activation of CRF cells in the dmPFC and vmPFC may trigger different effects on
local circuitry, and the output balance between these two subregions may lead to
different condition assessments of the environment and behavioral responses (Moorman
and Aston-Jones, 2015). In the AC of adolescent binge-drinking animals, CRF
measurements were positively associated with cell activation locally as measured by
Egr-1 cell density in the control group but not in the alcohol group (Figure 13). Similar
positive correlations were found in the PrL and IL of the alcohol-drinking rats but not in
the control rats (Figure 13 and Table 6). These results suggest that subregional
differences in the function of CRF in the mPFC can be altered by experience with alcohol.
Limitations of prefrontal CRF measurements
Immunohistochemistry was a major approach to access peptide levels of CRF in
the mPFC in this dissertation. This method has an advantage of anatomical resolution,
which provides information about the specific location of CRF cells and their neuronal
processes within the subregions and layers of the mPFC. This is essential to map the
local microcircuitry of the mPFC and to understand whether specific subpopulations of
mPFC CRF cells change after stress or alcohol. Micropunches on thick brain slices also
provides protein and mRNA levels of CRF in distinct subregions of the mPFC. However,
this method loses the anatomical resolution of the soma and neuronal processes, and
layer-specific analysis cannot be done. In addition, western blot analysis of CRF protein
levels is rarely done due to technical difficulties, but radioimmunoassay is a popular
alternative for measuring CRF protein level from tissue punches. Thus, CRF
immunohistochemistry is a good starting point for measuring CRF protein levels, but it
would be ideal to follow up these studies with more quantitative methods such as
radioimmunoassay.

112

After immunolabeling CRF, I quantified cell density and overall labeling intensity.
For CRF cell density, I counted all CRF cells in the subregions of the mPFC to avoid
biased sampling among all animals. Similarly, images used for quantifying CRF labeling
intensity were covered from layer II to VI within a subregion in order to measure both
CRF soma and fibers. Layer I was not included in labeling intensity analyses because
edges of brain slices accumulated non-specific signals. Neural peptides are synthesized
in the soma and then are transported to dendrites and axons. Activation of the cells
causes CRF release, which may temporarily deplete protein storage at the level of the
terminals. To restore the level of CRF in the terminals, CRF peptide in the soma is
transported down the axon. This could potentially result in depletion of peptide levels in
the soma until new CRF is synthesized again. When hypothalamic CRF cells release
peptide into the median eminence, it takes them at least 1.5 hours to restore the peptide
levels in the soma (Watts, 2005). Therefore, the release of CRF could change the
detectability of CRF cells in immunohistochemical studies. Taking the release of CRF
into consideration, a decrease in CRF cell number may be due to an increase in CRF
release or a decrease in CRF mRNA or protein synthesis; conversely, an increase in
CRF cell number may be due to a decrease in CRF release or an increase in CRF
mRNA or protein synthesis. Thus, multiple approaches such as microdialysis (although it
is technically challenging with this peptide), reverse transcription and quantitative
polymerase chain reaction, and radioimmunoassay for CRF detection would provide a
clearer picture of how CRF is regulated between treatments and sexes.
Potential roles of prefrontal CRF in the local microcircuitry
Possible factors that may contribute to CRF’s function among different mPFC
subregions are phenotypes of CRF cells and CRF terminal properties. CRF cells in the
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cortical areas have been reported as GABAergic inhibitory interneurons (Yan et al.,
1998), and these cells also express other neuropeptides such as vasoactive intestinal
peptide (VIP) and cholecystokinin. Recent evidence using transgenic mouse models
shows that VIP cells in the mPFC serve as disinhibitory neurons in the local circuitry (Pi
et al., 2013). To examine whether the phenotype of CRF cells differs across subregions
of the mPFC, CRF and VIP double-labeled cells were examined in mice. I found that the
AC had the highest CRF/VIP colocalization ratio when compared to PrL and IL (Figure
21). This subregional difference was mainly contributed by CRF/VIP colocalization in
puncta rather than in soma. The soma colocalization was higher in the upper layers of
the mPFC without a specific regional difference (Figure 21). When examining CRF
terminal properties using GAD as a GABAergic marker, I found that the AC had less
proportion of CRF/GAD colocalized puncta when compared to the PrL and IL in
adolescent rats (Figure 19). If colocalization with VIP or GAD indicates that those
terminals are likely to have disinhibitory or inhibitory functions, respectively, these results
suggest that CRF may be associated with disinhibitory functions toward dorsal portion of
the mPFC and with inhibitory functions toward ventral portion of the mPFC.
Sex differences in the prefrontal CRF system
Sex differences in the CRF system have been reported in different brain regions
and in different ages. For example, adult females have more CRF mRNA in the
paraventricular nucleus of the hypothalamus than males (Lenglos et al., 2015), and
adolescent females have fewer CRF cell numbers in the central nucleus of the amygdala
than males (Karanikas et al., 2013). Females and males also have age- and regiondifferential CRFR1 and CRFR2 expression (Weathington et al., 2014). In addition to
differences in the expression levels, adult female rats have higher CRFR1/G protein
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coupling than males in the locus coeruleus (Bangasser et al., 2010). These fundamental
differences may explain why males and females are more susceptible to substance
abuse and major depression, respectively. In the mPFC, I did not observe sex
differences in CRF peptide levels or CRF cell density among adolescent rats that drank
sweetened water or sweetened alcohol (Figure 12). Males and females also had similar
expression levels of CRF mRNA, CRF protein, and CRFR1 mRNA. The data of my
studies altogether suggest that sex differences in behavior are not likely attributable to
sex differences in cortical CRF cells.
There are several factors that should be considered for the interpretation of these
findings. During adolescence, male and female rats have increased levels of circulating
sexual hormones (Juraska et al., 2013). Hormonal rises induce sexual maturation and
related structural changes in both adolescent male and female rats (Ojeda et al., 1980;
Kolho et al., 1988). Using genital morphological indices, i.e. preputium separation for
males and vaginal opening for females, in our laboratory we found that adolescent
female rats reach puberty between postnatal day (PD) 30 and 35 and adolescent male
rats reach puberty around PD 42 (Karanikas et al. unpublished observation). Hormonal
fluctuations in females due to the estrous cycle influence behaviors. For example, adult
female rats show lower anxiety-like behaviors in proestrus than animals in other stages
of estrus cycles (Frye et al., 2000). Because the prefrontal CRF administration can elicit
anxiety-like behavior (Jaferi and Bhatnagar, 2007; Ohata and Shibasaki, 2011; Miguel et
al., 2014), it was hypothesized that these cells would show sex differences under
baseline conditions, and/or this system may respond to fluctuated hormonal levels and
lead to differential anxiety levels in males and females. I collected adolescent male and
female brains on PD43 because anxiety-like behavior was different at this young age.
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However, it should be noted that this was an age when most – but not all – males
reached puberty and most females started cycling. Thus, individual differences in sexual
maturity or estrous status could increase variability in the data and potentially mask an
effect of sex. It is also possible that sex differences of the CRF system in the mPFC
would be found with other mechanisms or conditions, such as receptor kinetics, coupling
to second messenger systems, or after animals are challenged by stressors.
Changes in subcortical regions in predator odor stress and adolescent binge
drinking models
Different subcortical CRF populations have been implicated in the development
and maintenance of alcohol use disorder. The hypothalamic CRF population is involved
in the dampened HPA axis after alcohol dependence, which is a known driving force to
increased alcohol drinking (Li et al., 2011, and see review in Lu and Richardson, 2014).
In addition, subcortical CRF populations in the bed nucleus of the stria terminalis (BNST)
and central nucleus of the amygdala (CeA) are known to contribute to two key
components of alcohol dependence: heightened anxiety when alcohol is unavailable and
relapsing to heavy drinking when alcohol is made available (Heilig and Koob, 2007;
Koob, 2008; Becker and Happel, 2012; Stephens and Wand, 2012). Elevated CRF
release during acute withdrawal has been found in the CeA (Merlo Pich et al., 1995).
This corresponds with escalated drinking behaviors as well. Systemic delivery of CRF1
receptor antagonists decrease escalated drinking behavior in the post-dependent stage
(Funk et al., 2007; Richardson et al., 2008b). When a CRF1 receptor antagonist is
delivered locally into the CeA, it takes much lower doses to prevent the relapse-like
drinking during the acute withdrawal (Funk et al., 2006).
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Increased CRF release has also been observed in the BNST after a prolonged
alcohol diet paradigm. When alcohol is made available again after a short period of
abstinence, the level of extracellular CRF decreases in the BNST (Olive et al., 2002).
CRF in the BNST has no direct effect on the relapse-like drinking (Funk et al., 2006) but
it may correspond to the heightened anxiety-like behavior (Davis et al., 1997). Activation
of CRF1 receptor has been known to have an anxiogenic effect. Both genetic knockout
of CRF1 receptor and application of CRF1 receptor antagonist decrease anxiety-like
behaviors (Smith et al., 1998; Timpl et al., 1998; Müller et al., 2003; Gutman et al., 2011;
Refojo et al., 2011). Administration of a CRF1 receptor antagonist also effectively
reduced the anxiety-like behaviors in both acute withdrawal and protracted abstinence
(Rassnick et al., 1993; Valdez et al., 2002; Knapp et al., 2004). This suggests that the
augmented CRF1 sensitivity is prolonged throughout the abstinence period and this may
contribute to an enhanced negative emotional drive and to an increased drinking.
The prefrontal CRF system was hypothesized to be one of the first CRF systems
to undergo adaptation after stress or alcohol exposure, and this change is proposed to
contribute to the development of alcohol use disorder (Figure 5 and see review in Zorrilla
et al., 2014). Using predator odor stress model, I found stress-induced changes in CRF
cell number only in the vmPFC but not in the dmPFC or in the CeA, dlBNST, and PVN.
Because this change was only observed in Avoiders, which were known to be high
stress-reactive and high alcohol-drinking animals, it is possible that an increase of CRF
cell number in the vmPFC may predispose future escalated drinking. It is also possible
that CRF cells were involved in the avoidance learning and related behaviors
(Moscarello and LeDoux, 2013; Bravo-Rivera et al., 2014) and had indirect or less
contribution to escalated drinking. In the adolescent binge-drinking model, CRF cells in
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the CeA may be more sensitive to binge history than CRF populations in the mPFC,
dlBNST, and PVN. Although no treatment effects were observed in the dlBNST and PVN,
more CRF cells in the dlBNST and fewer CRF cells in the PVN were associated with
higher drinking in binge animals. No treatment effects in the CRF cells of the dlBNST
and PVN suggest that CRF cells in these two regions may be predisposing factors to
alcohol drinking. In the mPFC and CeA, a decrease in CRF measurements with no
correlations between CRF measurements and alcohol intake were observed. However, if
high CRF predisposes animals to heavy drinking but alcohol downregulates this peptide,
then alcohol would not be expected to correlate with CRF indices in these two brain
regions. That is, the two opposing effects of predisposition and neuroadaptive changes
after alcohol would abolish this relationship. Taken together, these data suggest a
reciprocal relationship between alcohol and CRF populations in the brain, and the
sequence of changes in different CRF populations may not correspond with certain
symptoms of alcohol use disorder. Instead, the balance between CRF signaling in
multiple regions within the brain could play a critical role in the development of alcohol
use disorder.
Future directions
The studies of this dissertation suggest that the CRF system in the mPFC has a
bidirectional relationship with escalated drinking. At the behavioral level, future studies
should test the causal relationship empirically between dysfunction of the CRF system
and increased alcohol drinking or impaired executive functions by local manipulation of
this system using pharmacology, viral vectors, transgenic mice, or optogenetics. At the
circuitry level, the upstream and downstream signals of these CRF cells are still
unknown. The CRF cells in the mPFC may respond directly to alcohol or to other
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neuromodulatory signals, such as norepinephrine inputs from the locus coeruleus. In
addition, knowing how CRF cells connect to their postsynaptic cells within or outside of
the mPFC would clarify how CRF modulates cellular activity. At the cellular level, the
detailed electrophysiological properties of the CRF cells in the mPFC are still unknown.
The literature also shows complicated effects of CRF and other neuromodulators on
pyramidal neurons. It is possible that CRF in the mPFC may have multiple functions and
those functions are condition-dependent. Moreover, sex differences may emerge from
cellular properties and/or cell phenotypes. Future studies should combine both males
and females to further investigate neural mechanisms of sex differences in the
prevalence of different stress-related disorders. These mechanistic findings will expand
our understanding of the brain stress responsive system and provide potential
individualized treatment targets for both men and women in the future.
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Figure 21. CRF and VIP differentially colocalized in the soma and puncta across
mPFC subregions and cortical layers in adult male mice.
A. Double-labeling of CRF and VIP in the mice mPFC. DAPI labeling was used to define
different cortical layers. Scale bar, 50 µm. B. Quantification result of the number of CRF
structures that also contained VIP-positive signals. (Top) Puncta were defined when
area size was smaller than 2 µm2. The AC had the highest percentage of colocalization
without specific layer differences. (Middle) CRF-positive labeled cells were defined by
the size and circularity (see Materials and methods). Interestingly, layer 5/6 had the
lowest percentage of CRF and VIP co-expressed cells when compared to other layers.
In addition, no specific subregional differences were observed. (Bottom) The AC had the
highest percent of CRF/VIP colocalization and no specific differences were found across
different layers. Abbreviations, AC, anterior cingulate cortex; PrL, prelimbic cortex; IL,
infralimbic cortex. Four wild-type mice were used in this study.
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APPENDIX I
SUPPLEMENTARY RESULTS
Formaldehyde-fixation is a common laboratory procedure to preserve tissue. This
method is also used to prepare samples for histological analyses of cellular morphology
and protein markers. Formaldehyde-fixed tissue can be sampled to measure DNA
sequence and gene expression levels (e.g. Walther et al., 2015). However, the detection
of nucleic acids can be hampered by RNA fragmentation that occurred during prolonged
tissue storage, especially when tissues are preserved for longer than one year (Ahlfen et
al., 2007). The quantification of RNA abundance is nonetheless possible at certain levels
of RNA degradation by reverse transcription polymer chain reaction (RT-PCR) of
complementary DNA (cDNA) templates when PCR products are less than 500 bp
(Ahlfen et al., 2007). Thus, the level of RNA degradation, or more specifically, the size of
degraded fragments, is critical for gene expression analyses.
To examine RNA fragmentation of formaldehyde-fixed brain slices, twelve RNA
samples from medial prefrontal cortices were analyzed using an Agilent Bioanalyzer
2100 with a RNA 6000 Nano chip. This method is capable of analyzing 5 to 500 ng of
RNA, which is ideal for the limited amount of RNA that was extracted from regionspecific dissections of perfused brain slices. Figure 22 shows an example of RNA quality
analysis using an Agilent Bioanalyzer adapted from the University of Texas Medical
Branch at Galveston Molecular Genomics Core. Because ribosomal RNA (rRNA)
species are the most abundant types of RNA in mammalian cells, clear 28S and 18S
rRNA bands indicate highly intact RNA samples. Degradation of rRNA species has been
used as an estimate of overall RNA degradation. When RNA samples are degraded,
additional signals and/or a smearing pattern would be observed together with a shift
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toward shorter RNA fragments (Figure 22). The quality of my RNA samples was
comparable to samples 6 and 7 in Figure 22 (Figure 23A). In addition, substantial signals
were detected in the high molecular-weight range. This result suggests that my
experimental RNA samples were partially degraded with mostly larger RNA fragments
being preserved. While the overall level of degradation can be a poor predictor of
successful gene expression analyses; the mean RNA fragment size is a more reliable
determinant (Ahlfen et al., 2007; Illumina, 2014a). Taking RT-qPCR as an example, if
input cDNA templates are generated from extremely fragmented RNAs, then primers of
target genes will not be able to anneal to the cDNA. This will lead to low amplification (i.e.
high Ct value). Illumina Inc. proposed a new metric, DV200, to categorize the suitability of
an RNA sample for sequencing (Illumina, 2014a). Using 200 nucleotides as a cutoff for
long and short RNA fragments, the percentage of long RNA fragments over all RNA
fragments was estimated using the Nano chip results and ImageJ intensity analysis.
Samples with more than 30% of the long RNA fragments are suitable for sequencing and
gene expression analysis (Illumina, 2014b; Walther et al., 2015). My RNA samples
contained 79 to 92% of the RNA fragments being greater than 200 nucleotides (Table
11). This suggests that the RNA samples extracted from formaldehyde-fixed tissues in
my experiments were of suitable quality for gene expression analyses.
To optimize the cDNA template length, a mixture of random hexamers and oligodT was used in the cDNA synthesis reactions. In addition, the sizes of the PCR products
were all below 250 bp, which decreases suboptimal conditions of amplifying long
products from fragmented templates (Ahlfen et al., 2007). Dilution curves were examined
using 18S rRNA and cyclopilin A (CypA) primers (Figure 24). A linear relationship
between the amount of cDNA input and amplicons were detected with an R square of
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0.99. These results indicate that the relative amount of transcript can be measured
precisely despite partial fragmentation and degradation of the original RNA templates.
The specificity of CRF and CRFR1 primers was tested using different types of templates.
A few dilutions were also examined for CRF and CRFR1 transcripts. There similar trend
of a linear relationship between the amount of cDNA input and amplicons (Figure 25).
Because CRF and CRFR1 are both less abundant than the housekeeping genes used in
the study, it is possible that any effect of RNA degradation and/or chemical modifications
could have a disproportionate impact on rare transcripts. It is worth noting that capillary
gel electrophoresis (Bioanalyzer) and gel electrophoresis provide an estimate of RNA
quality through the analysis of rRNA and not specific messenger RNA (mRNA). Thus, a
possible differential degradation of specific RNAs between individual animals or between
treatment groups cannot be excluded. Further analyses using, for example, Northern blot
or RNA sequencing methods could reveal degradation profiles of specific genes in
formaldehyde-fixed brain slices.
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Figures and Tables
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Figure 22. An example of different levels of RNA degradation.

A

Equal amounts of HeLa cell RNA (250 ng) with different levels of RNA degradation are
analyzed using a Bioanalyzer 2100 (Agilent). Lane 1 and 12 show highly intact RNA with
distinct 28S and 18S rRNA bands. RNA samples from lanes 2 to 11 show low-to-high
degradation levels. L, ladder; nt, nucleotide; [s], seconds. Adapted from Molecular
M
Genomics Core, M
The UniversityF of Texas Medical
Branch F
at Galveston (RNA/DNA
Quality Assessment,
http://www.scmm.utmb.edu/genomics/isolation/qc.asp).
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Figure 23. Integrity of RNA isolated from perfused brain slices of adolescent male
and female rats.
A. The digital gel obtained from an Agilent 2100 Bioanalyzer demonstrated the integrity
of twelve RNA samples that were used for CRF and CRFR1 expression levels in Chapter
4. The smearing pattern in each lane with more signals toward high molecular weight
indicated partial RNA degradation. Although RNAs were partially degraded, fragments
larger than 200 nucleotides (nt) were major RNA species in each sample (79-92%,
analyzed using ImageJ intensity measurement, Table 11). These large fragments were
still feasible for gene expression analysis using a RT-qPCR method (Ahlfen et al., 2007).
M, males; F, females. B. An electropherogram of RNA ladders. Each peak corresponded
to a band in the ladder of the gel image. C. Individual electropherograms for males and
females.
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Figure 24. Dilution curves of two house keeping genes, 18S rRNA and cyclophilin
A (CypA).
A. A serial dilution of cDNA input was used to examine the amplification efficiency in
qPCR reactions. The maximum input here was used as a comparison baseline. Both xand y-axes were presented in a log scale with a base of 10. B. A data table with raw
cycle number (Ct value), expected results, and acquired results from the reaction. Each
data point was an average of duplicates.
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Figure 25. CRF and CRFR1 primer tests using different types of templates.
A. Fresh-frozen tissue and perfused brain slices showed similar amplification efficiency
using CRF or CRFR1 primers. B. Expected and acquired results of CRF and CRFR1
amplification using different types of templates. Despite different types of templates were
used, same melting temperature was detected when CRF was amplified. Similar results
were acquired using CRFR1 primers (data not shown). It is worth noting that with the
same amount of cDNA input, a reverse transcribed (RT) sample contains a thousand
times more PCR products than no RT controls.
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Table 11. Results of the percentage of RNA fragments over 200 nucleotides (nt)
from twelve examined formaldehyde-fixed RNA samples.
Sample

RNA fragments >
200 nt (sum of
pixel values)

Total RNA
fragments (sum of
pixel values)

The percentage of
RNA fragments over
200 nucleotides

1

817374

887846

92.06

2

811026

900036

90.11

3

683560

850862

80.34

4

837706

958962

87.36

5

666862

839270

79.46

6

768844

852196

90.22

7

890238

998568

89.15

8

783610

902382

86.84

9

870090

1020878

85.23

10

783518

940608

83.30

11

807622

925152

87.30

12

863512

961906

89.77
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APPENDIX II
SUPPLEMENTARY METHODS
CRF/VIP double immunofluorescent labeling
Mouse prefrontal brain sections (1.98 mm to 1.18 mm from Bregma) were sorted
and double labeled with corticotropin-releasing factor (CRF) and vasoactive intestinal
peptide (VIP) using free-floating immunolabeling method. Cryoprotectant was removed
by PBS and 0.1M PBS with 0.3% Triton X-100 (PBST) rinses. A 20-min incubation with
50 mM ammonium chloride in 0.1M PBST was used to reduce the tissue
autofluorescence from the fixative. Another 30-min incubation with 3% hydrogen
peroxide (H2O2) in PBS was used to quench the endogenous peroxidase activity.
Afterwards, sections were blocked by 5% non-fat milk in PBS for 1 hr before proceeding
to the antiserum incubation. The rabbit anti h/r CRF antiserum (1:20,000, gift from Dr.
Paul Sawchenko at the Salk Institute, La Jolla, CA) was prepared in 3% normal goat
serum (NGS) in PBST. The CRF antibody incubation was carried at 4ºC for 14-18 hr.
The biotinylated goat anti rabbit antiserum (1:200, prepared in 5% NGS/2% BSA/PBS)
was used to recognize CRF antibody under 2-hr room temperature incubation. A 1-hr
incubation with ABC kit (Vector Laboratories) was used before the 5 min signal
development with Ampliflu Red (red fluorescence, 1:5,000 in 3% H2O2/ PBS, SigmaAldrich). After another series of PBST rinses, rabbit anti VIP antiserum (1:400, prepared
in 3% NGS/ PBST, ImmunoStar) was applied for 14-18 hr at 4ºC. The VIP antiserum
was recognized by Cy2-conjugated goat anti rabbit antiserum (1:300, Jackson
ImmunoResearch Laboratories, Inc.). A control group with CRF labeling followed by Cy2conjugated goat anti-rabbit antiserum incubation showed low or no interaction between
this secondary antiserum and CRF antiserum (data not shown). The 4',6-diamidino-2phenylindole (DAPI) staining (1:10,000 from 0.1% stock solution, Invitrogen) was used
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for the nucleus visualization. Sections were mounted onto the gelatin-coated subbed
slides and coverslipped with DPX mountant (Sigma-Aldrich) before microscopic analyses.
CRF/VIP Imaging acquisition and process
Prefrontal sections were sampled between 1.78 mm to 1.42 mm from Bregma
using corpus callosum as an anatomical marker. Each animal was sampled for total 4
hemispheres. Zeiss LSM 700 confocal microscope was used for acquiring images
(Markstein Lab, University of Massachusetts Amherst). Images were taken at anterior
cingulate cortex (AC), prelimbic cortex (PrL), and infralimbic cortex (IL) using a 20X
objective. One by three horizontal tile scan was used to cover layer 1 to 6 in the sampled
area. Z-stack images were taken at every 1.32 µm step and total 3-5 µm thickness of
section was examined. Images after the maximum projection from the Z-stack images
was used for the analyses. Cortical layers were determined by the DAPI labeling based
on the nuclei size and distribution throughout the sampled area. All image analysis was
performed using ImageJ software and built-in plug-in packages. Cell counter Plugin was
used to manually count the numbers of VIP immunoreactive (VIP-ir), CRF
immunoreactive (CRF-ir), and double-labeled cells at different layers. The counted
number from each subregions, layers, and cell types were averaged across
hemispheres. An object-based analysis was used for puncta analysis. CRF-labeled
images were background subtracted, thresholded using the default method, and then
transformed into a binary mode. The binary images were processed with despeckle once.
A function of Analyze particles was used to identify structures at varied sizes and the
identified particles were added into the ROI manager. Those ROIs were overlaid to the
VIP labeled images to acquire the labeling intensity of VIP within each CRF particles. A
threshold for VIP labeling intensity was defined by mean plus three standard variations
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of all VIP images. CRF particles with VIP labeling intensity below the threshold were
removed from analysis. Based on the size of identified particles, 50-250 µm2 with
circularity over 0.2 was defined as soma, and particles below 2 µm2 were defined as
puncta. The percent colocalization was defined as (colocalized particle number ÷ total
CRF positive particle number x 100).
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